Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
104000,,2123990,CHEMBL935984,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in immunocompetent CD1 mouse with peritonitis at 50 mg/kg, sc relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,90.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,90.0
104001,,2123992,CHEMBL935986,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in immunocompetent CD1 mouse with peritonitis at 50 mg/kg, sc after 3 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,96.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,96.0
104002,,2123993,CHEMBL935987,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in immunocompetent CD1 mouse with peritonitis at 50 mg/kg, sc after 4 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,98.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,98.0
104003,,2123995,CHEMBL935988,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in immunocompetent CD1 mouse with peritonitis at 50 mg/kg, sc after 5 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,99.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.0
104004,,2124001,CHEMBL935285,"Reduction in bioluminescent methicillin-resistant Staphylococcus aureus Xen1 in neutropenic CD1 mouse with peritonitis at 50 mg/kg, sc after 2 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,93.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,93.0
104005,,2124002,CHEMBL935286,"Reduction in bioluminescent methicillin-resistant Staphylococcus aureus Xen1 in neutropenic CD1 mouse with peritonitis at 50 mg/kg, sc after 3 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,99.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.0
104006,,2124003,CHEMBL935287,"Reduction in bioluminescent methicillin-resistant Staphylococcus aureus Xen1 in neutropenic CD1 mouse with peritonitis at 50 mg/kg, sc after 5 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.9
104007,,2124010,CHEMBL936081,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in neutropenic CD1 mouse with peritonitis at 50 mg/kg, sc after 3 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,98.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,98.0
104008,,2124011,CHEMBL936082,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in neutropenic CD1 mouse with peritonitis at 50 mg/kg, sc after 4 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,99.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.4
104009,,2124012,CHEMBL936083,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in neutropenic CD1 mouse with peritonitis at 50 mg/kg, sc after 5 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,99.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.7
104010,,2124013,CHEMBL935398,"Reduction in bioluminescent methicillin-sensitive Staphylococcus aureus Xen29 in neutropenic CD1 mouse with peritonitis at 50 mg/kg, sc after 2 hrs relative to control",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1144463,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,703762,=,1,0,=,Activity,%,92.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,92.0
104011,Active,2125236,CHEMBL937014,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by silicone disk biofilm colonization method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1145511,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,705840,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104012,Active,2125239,CHEMBL937015,Antibacterial activity against methicillin-resistant Staphylococcus aureus at 4 hrs daily exposure for 2 days,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1145511,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,705840,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104013,,2126516,CHEMBL935009,Antimicrobial activity against Streptococcus pneumoniae WB4 by broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143816,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702325,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.06
104014,,2126522,CHEMBL935011,Antimicrobial activity in Streptococcus pneumoniae WB4 infected New Zealand white rabbit meningitis model assessed as decrease in viable cells in CSF at 15 mg/kg after 8 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143816,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,702325,=,1,0,=,log10CFU/ml,,-6.64,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10CFU/ml,,,-6.64
104015,,2126524,CHEMBL935110,Antimicrobial activity in Streptococcus pneumoniae WB4 infected New Zealand white rabbit meningitis model assessed as increase in [3H]choline release in CSF at 15 mg/kg after 4 hrs,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143816,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,702325,=,1,0,=,Activity,cpm/min,250.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,cpm/min,,250.0
104016,,2126559,CHEMBL935227,"Decrease in TNFalpha level in Streptococcus pneumoniae infected Wistar rat CSF at 50 mg/kg, sc after 24 hrs by ELISA",F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/PicogramPerMilliliter,702675,=,1,0,=,Activity,pg/ml,352.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,pg/ml,,352.0
104017,Active,2126561,CHEMBL936039,"Antimicrobial activity against Streptococcus pneumoniae infected Wistar rat CSF assessed as decrease in bacterial titer at 50 mg/kg, sc after 6 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,702675,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104018,,2126566,CHEMBL935230,"Effect on Streptococcus pneumoniae infection induced elevation of MMP9 level in Wistar rat CSF assessed as MMP-9/MMP-2 index at 50 mg/kg, sc after 20 hrs by gel zymography",F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,702675,=,1,0,=,Ratio,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,1.6
104019,,2126567,CHEMBL935231,"Effect on Streptococcus pneumoniae infection induced elevation of MMP9 level in Wistar rat CSF assessed as MMP-9/MMP-2 index at 50 mg/kg, sc after 24 hrs by gel zymography",F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,702675,=,1,0,=,Ratio,,1.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,1.2
104020,,2126568,CHEMBL935232,"Effect on Streptococcus pneumoniae infection induced elevation of MMP9 level in Wistar rat CSF assessed as MMP-9/MMP-2 index at 50 mg/kg, sc after 40 hrs by gel zymography",F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,702675,=,1,0,=,Ratio,,0.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,0.6
104021,,2126569,CHEMBL935224,Antibacterial activity against Streptococcus pneumoniae serotype 3,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702675,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.25
104022,,2126571,CHEMBL935225,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702675,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.38
104023,,2126574,CHEMBL935226,"Effect on TNFalpha level in Streptococcus pneumoniae infected Wistar rat CSF at 50 mg/kg, sc after 2 to 6 hrs y ELISA",F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/PicogramPerMilliliter,702675,=,1,0,=,Activity,pg/ml,3059.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,pg/ml,,3059.0
104024,Not Active,2126578,CHEMBL936041,"Reduction of Streptococcus pneumoniae infection induced cortical brain damage in Wistar rat at 50 mg/kg, sc after 40 hrs",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,702675,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104025,,2126582,CHEMBL936043,"Effect on Streptococcus pneumoniae infection induced brain injury in Wistar rat hippocampal dentate gyrus assessed as number of apoptotic cells at 50 mg/kg, sc after 20 hrs",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,702675,=,1,0,=,Activity,%,5.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,5.5
104026,,2126583,CHEMBL935348,"Effect on Streptococcus pneumoniae infection induced brain injury in Wistar rat hippocampal dentate gyrus assessed as number of apoptotic cells at 50 mg/kg, sc after 24 hrs",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,702675,=,1,0,=,Activity,%,14.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,14.9
104027,,2126584,CHEMBL935349,"Effect on Streptococcus pneumoniae infection induced brain injury in Wistar rat hippocampal dentate gyrus assessed as number of apoptotic cells at 50 mg/kg, sc after 40 hrs",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143818,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,702675,=,1,0,=,Activity,%,6.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,6.1
104028,,2127596,CHEMBL938265,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A8090 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104029,,2127597,CHEMBL938266,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A8094 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104030,,2127598,CHEMBL938267,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A6224 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104031,,2127599,CHEMBL938268,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A6226 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104032,,2127600,CHEMBL938269,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A6300 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104033,,2127601,CHEMBL952984,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A6298 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104034,,2127602,CHEMBL952985,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A8796 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104035,,2127603,CHEMBL952986,Antimicrobial activity against methicillin-resistant Staphylococcus aureus A8799 with mprF S337L mutation by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1143853,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703551,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104036,,2303026,CHEMBL1001605,Antimicrobial activity against panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus 490 after 14 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104037,,2303030,CHEMBL1001601,Antimicrobial activity against panton-valentine leukocidin-negative community-acquired methicillin-resistant Staphylococcus aureus 481 after 14 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104038,Not Determined,2303032,CHEMBL1004899,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after 50 passages with vancomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104039,,2303033,CHEMBL1004898,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after 18 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104040,,2303034,CHEMBL1004897,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after 15 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104041,,2303035,CHEMBL1004896,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after 17 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104042,,2303036,CHEMBL1004895,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104043,Not Determined,2303037,CHEMBL1004894,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after 50 passages with vancomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104044,,2303038,CHEMBL1004893,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after 16 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104045,,2303039,CHEMBL1004892,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after 36 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104046,,2303040,CHEMBL1004891,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after 24 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104047,,2303041,CHEMBL1004890,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104048,Not Determined,2303042,CHEMBL1004889,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 555 Hershey after 50 passages with vancomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104049,,2303043,CHEMBL1004888,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 555 Hershey after 20 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104050,Not Determined,2303044,CHEMBL1004073,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 555 Hershey after 50 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104051,Not Determined,2303045,CHEMBL1004072,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 555 Hershey after 50 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104052,,2303046,CHEMBL1004071,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 555 Hershey after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104053,Not Determined,2303047,CHEMBL1004070,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after 50 passages with vancomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104054,,2303048,CHEMBL1004069,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after 21 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104055,,2303049,CHEMBL1004068,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after 48 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104056,,2303050,CHEMBL1004067,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after 21 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104057,,2303051,CHEMBL1004066,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104058,Not Determined,2303052,CHEMBL1004065,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after 50 passages with vancomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104059,,2303053,CHEMBL1004064,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after 16 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104060,Not Determined,2303054,CHEMBL1004063,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after 50 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104061,,2303055,CHEMBL1004062,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after 20 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104062,,2303056,CHEMBL1004061,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104063,,2303057,CHEMBL1001465,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 510 Hershey after 14 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104064,Not Determined,2303058,CHEMBL1001464,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 510 Hershey after 50 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104065,,2303059,CHEMBL1001463,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 510 Hershey after 18 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104066,,2303060,CHEMBL1001462,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 510 Hershey after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104067,,2303061,CHEMBL1001459,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 509 Michigan after 18 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104068,,2303062,CHEMBL1001458,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 509 Michigan after 28 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104069,,2303063,CHEMBL1001457,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 509 Michigan after 20 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104070,,2303064,CHEMBL1001456,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 509 Michigan after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104071,Not Determined,2303065,CHEMBL1001455,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 504 after 50 passages with vancomycin measured after 10 times antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104072,,2303066,CHEMBL1001454,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 504 after 16 passages with quinupristin-dalfopristin measured after 10 times antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104073,,2303067,CHEMBL1001453,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 504 after 22 passages with Linezolid measured after 10 times antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104074,Not Determined,2303068,CHEMBL1000559,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 504 after 50 passages with daptomycin measured after 10 times antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104075,,2303069,CHEMBL1000558,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 504 after 14 passages with CG400549 measured after 10 times antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104076,Not Determined,2303070,CHEMBL1000557,Antimicrobial activity against panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus 490 after 50 passages with vancomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104077,,2303071,CHEMBL1000556,Antimicrobial activity against panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus 490 after 23 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104078,,2303072,CHEMBL1000555,Antimicrobial activity against panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus 490 after 22 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104079,,2303073,CHEMBL1000554,Antimicrobial activity against panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus 490 after 14 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104080,,2303074,CHEMBL1000553,Antimicrobial activity against panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus 490 after 17 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104081,Not Determined,2303075,CHEMBL1000552,Antimicrobial activity against panton-valentine leukocidin-negative community-acquired methicillin-resistant Staphylococcus aureus 481 after 50 passages with vancomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,783680,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104082,,2303076,CHEMBL1000551,Antimicrobial activity against panton-valentine leukocidin-negative community-acquired methicillin-resistant Staphylococcus aureus 481 after 16 passages with quinupristin-dalfopristin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104083,,2303077,CHEMBL1000550,Antimicrobial activity against panton-valentine leukocidin-negative community-acquired methicillin-resistant Staphylococcus aureus 481 after 37 passages with Linezolid measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104084,,2303078,CHEMBL1000549,Antimicrobial activity against panton-valentine leukocidin-negative community-acquired methicillin-resistant Staphylococcus aureus 481 after 14 passages with daptomycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104085,,2303079,CHEMBL1000548,Antimicrobial activity against panton-valentine leukocidin-negative community-acquired methicillin-resistant Staphylococcus aureus 481 after 14 passages with CG400549 measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104086,,2303080,CHEMBL1001600,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104087,,2303081,CHEMBL1001599,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104088,,2303082,CHEMBL1001598,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 555 Hershey by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
104089,,2303083,CHEMBL1001597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104090,,2303084,CHEMBL999696,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104091,,2303085,CHEMBL999695,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 510 Hershey by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104092,,2303086,CHEMBL999694,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 509 Michigan by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104093,,2303087,CHEMBL999693,Antimicrobial activity against community-acquired vancomycin-intermediate Staphylococcus aureus 504 by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104094,,2303088,CHEMBL999692,Antimicrobial activity against panton-valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus 490 by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104095,,2303089,CHEMBL999691,Antimicrobial activity against panton-valentine leukocidin-negative community-acquired methicillin-resistant Staphylococcus aureus 481 by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104096,,2303266,CHEMBL999711,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 504 after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
104097,,2303269,CHEMBL999714,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 509 Michigan after 20 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104098,,2303272,CHEMBL1000529,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 510 Hershey after 18 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104099,,2303275,CHEMBL1000532,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after 20 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104100,,2303279,CHEMBL1000535,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after 21 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104101,,2303285,CHEMBL1000539,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 555 Hershey after 50 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
104102,,2303287,CHEMBL1000541,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after 24 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104103,,2303291,CHEMBL1000545,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after 17 passages by multi-step resistance selection technique,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104104,,2304404,CHEMBL1001460,Antimicrobial activity against methicillin and vancomycin-resistant Staphylococcus aureus 510 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104105,,2304405,CHEMBL1001461,Antimicrobial activity against methicillin and vancomycin-resistant Staphylococcus aureus 509 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104106,,2304406,CHEMBL1004900,Antimicrobial activity against methicillin-resistant vancomycin-intermediate Staphylococcus aureus 555 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104107,,2304407,CHEMBL1004901,Antimicrobial activity against methicillin-resistant vancomycin-intermediate Staphylococcus aureus 504 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104108,,2304408,CHEMBL1004902,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 481 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104109,,2304409,CHEMBL1004903,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 490 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104110,,2304410,CHEMBL1004904,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104111,,2304411,CHEMBL1004905,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104112,,2304412,CHEMBL1004906,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104113,,2304413,CHEMBL1004907,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after single-step resistance selection by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104114,,2304415,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104115,,2304421,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
104116,,2304427,CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
104117,,2304433,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104118,,2304439,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104119,,2304445,CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783680,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104120,,2496166,CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.12
104121,,2496176,CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.12
104122,,2496186,CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,mg/L,UO_0000274,0.12
104123,,2496196,CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,mg/L,UO_0000274,0.12
104124,,2496206,CHEMBL983324,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg/L,UO_0000274,0.015
104125,,2496212,CHEMBL983325,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,mg/L,UO_0000274,0.5
104126,,2496218,CHEMBL983326,Antibacterial activity against vancomycin-susceptible Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,mg/L,UO_0000274,0.03
104127,,2496224,CHEMBL983327,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,mg/L,UO_0000274,0.25
104128,,2496230,CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.06
104129,,2496241,CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.03
104130,,2496252,CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.06
104131,,2496263,CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC,mg/L,UO_0000274,0.03
104132,,2496274,CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,mg/L,UO_0000274,0.06
104133,,2497050,CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,mg/L,UO_0000274,0.03
104134,,2497063,CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,mg/L,UO_0000274,0.25
104135,,2497073,CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,mg/L,UO_0000274,0.5
104136,,2497083,CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,mg/L,UO_0000274,0.5
104137,,2497093,CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,mg/L,UO_0000274,0.5
104138,,2497103,CHEMBL983324,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,mg/L,UO_0000274,1.0
104139,,2497109,CHEMBL983325,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,mg/L,UO_0000274,0.5
104140,,2497115,CHEMBL983326,Antibacterial activity against vancomycin-susceptible Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,mg/L,UO_0000274,2.0
104141,,2497121,CHEMBL983327,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,mg/L,UO_0000274,2.0
104142,,2497127,CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,mg/L,UO_0000274,0.12
104143,,2497138,CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,mg/L,UO_0000274,0.12
104144,,2497149,CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,mg/L,UO_0000274,0.12
104145,,2497160,CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC50,mg/L,UO_0000274,0.06
104146,,2497171,CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC50,mg/L,UO_0000274,0.25
104147,,2497182,CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,mg/L,UO_0000274,0.5
104148,,2497193,CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,0.5
104149,,2497203,CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,0.5
104150,,2497213,CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,mg/L,UO_0000274,1.0
104151,,2497223,CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,mg/L,UO_0000274,0.5
104152,,2497233,CHEMBL983324,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,mg/L,UO_0000274,2.0
104153,,2497239,CHEMBL983325,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,mg/L,UO_0000274,2.0
104154,,2497245,CHEMBL983326,Antibacterial activity against vancomycin-susceptible Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,mg/L,UO_0000274,4.0
104155,,2497251,CHEMBL983327,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,mg/L,UO_0000274,2.0
104156,,2497257,CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,0.25
104157,,2497268,CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,0.25
104158,,2497279,CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,mg/L,UO_0000274,0.12
104159,,2497290,CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC90,mg/L,UO_0000274,0.06
104160,,2497301,CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC90,mg/L,UO_0000274,0.25
104161,,2497312,CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780048,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,mg/L,UO_0000274,1.0
104162,Dose-dependent effect,2574047,CHEMBL984649,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells after 24 hrs in presence of 1 mg/liter daptomycin,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104163,,2574048,CHEMBL982148,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells after 24 hrs,F,BAO_0000188,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742631,=,1,1,=,EC50,ug.mL-1,1.14,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,1.14
104164,,2574049,CHEMBL982149,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells assessed as concentration resulting in no apparent bacterial growth after 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Activity,mg/L,1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,1.3
104165,,2574050,CHEMBL982150,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells assessed as decrease in CFU at 1 mg/liter after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,log10cfu,,-1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-1.6
104166,,2574051,CHEMBL982151,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells after 24 hrs in presence of 100 uM verapamil,F,BAO_0000188,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742631,=,1,1,=,EC50,ug.mL-1,0.31,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,0.31
104167,,2574052,CHEMBL984632,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells assessed as concentration resulting in no apparent bacterial growth after 24 hrs in presence of 100 uM verapamil,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Activity,mg/L,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,0.4
104168,,2574053,CHEMBL984633,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells assessed as decrease in CFU at 1 mg/liter after 24 hrs in presence of 100 uM verapamil,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,log10cfu,,-1.82,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-1.82
104169,,2574054,CHEMBL984634,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells after 24 hrs in presence of 0.5 uM elacridar,F,BAO_0000188,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742631,=,1,1,=,EC50,ug.mL-1,0.27,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,0.27
104170,,2574055,CHEMBL984635,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells assessed as concentration resulting in no apparent bacterial growth after 24 hrs in presence of 0.5 uM elacridar,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Activity,mg/L,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,0.4
104171,,2574056,CHEMBL984636,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in human THP1 cells assessed as decrease in CFU at 1 mg/liter after 24 hrs in presence of 0.5 uM elacridar,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,log10cfu,,-1.67,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-1.67
104172,,2574057,CHEMBL984637,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells after 24 hrs,F,BAO_0000188,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742631,=,1,1,=,EC50,ug.mL-1,0.62,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,0.62
104173,,2574058,CHEMBL984638,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as concentration resulting in no apparent bacterial growth after 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Activity,mg/L,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,0.6
104174,,2574059,CHEMBL984639,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as decrease in CFU at 1 mg/liter after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,log10cfu,,-1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-1.7
104175,,2574060,CHEMBL984640,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells after 24 hrs in presence of 100 uM verapamil,F,BAO_0000188,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742631,=,1,1,=,EC50,ug.mL-1,0.18,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,0.18
104176,,2574061,CHEMBL984641,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as concentration resulting in no apparent bacterial growth after 24 hrs in presence of 100 uM verapamil,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Activity,mg/L,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,0.2
104177,,2574062,CHEMBL984642,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as decrease in CFU at 1 mg/liter after 24 hrs in presence of 100 uM verapamil,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,log10cfu,,-2.01,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-2.01
104178,,2574063,CHEMBL984643,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MADR1 at 1 mg/liter after 24 hrs,F,BAO_0000188,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742631,=,1,1,=,EC50,ug.mL-1,2.67,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,2.67
104179,,2574064,CHEMBL984644,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MADR1 assessed as concentration resulting in no apparent bacterial growth after 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Activity,mg/L,2.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,2.1
104180,,2574065,CHEMBL984645,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MADR1 assessed as decrease in CFU at 1 mg/liter after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,log10cfu,,-1.77,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-1.77
104181,,2574066,CHEMBL984646,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MADR1 after 24 hrs in presence of 100 uM verapamil,F,BAO_0000188,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742631,=,1,1,=,EC50,ug.mL-1,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,EC50,mg/L,UO_0000274,0.7
104182,,2574067,CHEMBL984647,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MADR1 assessed as concentration resulting in no apparent bacterial growth after 24 hrs in presence of 100 uM verapamil,F,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Activity,mg/L,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,mg/L,,0.6
104183,,2574068,CHEMBL984648,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MADR1 assessed as decrease in CFU at 1 mg/liter after 24 hrs in presence of 100 uM verapamil,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,log10cfu,,-1.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-1.78
104184,,2574074,CHEMBL985497,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.23,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.23
104185,,2574075,CHEMBL985498,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry in presence of 100 uM verapamil,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.83,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.83
104186,,2574076,CHEMBL985499,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry in presence of 1 uM ouabain,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.04,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.04
104187,,2574077,CHEMBL985500,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in wild type MDCK cells assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry in presence of 250 uM gemfibrozil,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.18,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.18
104188,,2574078,CHEMBL985501,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MDR1 assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.08,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.08
104189,,2574079,CHEMBL985502,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MDR1 cells assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry in presence of 100 uM verapamil,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.3,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.3
104190,,2574080,CHEMBL985503,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MDR1 cells assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry in presence of 1 uM ouabain,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.03,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.03
104191,,2574081,CHEMBL985504,Cellular uptake in methicillin-sensitive Staphylococcus aureus ATCC 25923 phagocytized in MDCK cells over expressing human MDR1 cells assessed as apparent cellular to extracellular concentration ratio at 250 mg/liter after 24 hrs by fluorimetry in presence of 250 uM gemfibrozil,A,BAO_0000179,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155173,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,742631,=,1,0,=,Ratio,mg/L,0.07,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,Ratio,mg/L,,0.07
104192,,2576283,CHEMBL992870,Antimicrobial activity against wild type vancomycin-intermediate resistant Staphylococcus aureus Mu50 by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742898,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104193,,2576300,CHEMBL992872,Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 vraG mutant microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742898,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104194,,2576317,CHEMBL992871,Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 graR mutant microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742898,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104195,Not Determined,2598087,CHEMBL1025802,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 43300,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,799147,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104196,Not Determined,2598088,CHEMBL1026585,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 6538,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,799147,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104197,,2598089,CHEMBL1026586,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 29213,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104198,,2598090,CHEMBL1026587,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 1137,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104199,,2598091,CHEMBL1026588,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus 2012,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104200,,2598092,CHEMBL1026589,Antimicrobial activity against linezolid-resistant methicillin-resistant Staphylococcus aureus 1725,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104201,Not Determined,2598093,CHEMBL1026590,Antimicrobial activity against vancomycin-resistant Enterococcus faecium 700221 clinical isolate,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,799147,,1,0,,MIC,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,,,
104202,,2598094,CHEMBL1026591,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae 975,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
104203,,2598095,CHEMBL1026592,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae 940,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
104204,,2598096,CHEMBL1026593,Antimicrobial activity against quinolone-resistant Streptococcus pneumoniae 376,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
104205,,2598097,CHEMBL1026594,Antimicrobial activity against ampicillin-resistant Haemophilus influenzae 1742,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,64.0
104206,,2598098,CHEMBL1026595,Antimicrobial activity against Haemophilus parainfluenzae 2319,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL614408,Haemophilus parainfluenzae,Haemophilus parainfluenzae,729.0,,MIC,ug ml-1,UO_0000274,64.0
104207,Not Determined,2598099,CHEMBL1026596,Antimicrobial activity against Escherichia coli 1411,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,799147,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
104208,,2598100,CHEMBL1026597,Antimicrobial activity against Escherichia coli 25922 QC,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
104209,,2598101,CHEMBL1026598,Antimicrobial activity against extended spectrum beta-lactamase producing Escherichia coli 2269,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
104210,,2598102,CHEMBL1026599,Antimicrobial activity against Klebsiella pneumoniae 2239,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
104211,,2598103,CHEMBL1026600,Antimicrobial activity against ampC beta-lactamase producing multidrug-resistant Klebsiella pneumoniae 2262,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
104212,,2598104,CHEMBL1026601,Antimicrobial activity against Moraxella catarrhalis 557,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,16.0
104213,,2598105,CHEMBL1026602,Antimicrobial activity against Serratia marcescens 1635,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,64.0
104214,,2598106,CHEMBL1026603,Antimicrobial activity against Pseudomonas aeruginosa 1473,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151720,J Nat Prod,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,799147,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
104215,,2661782,CHEMBL1025416,Bactericidal activity against exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc assessed as logarithmic reduction in CFU at 2 ug/ml within 60 mins by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,=,1,0,=,Activity,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,3.0
104216,,2661786,CHEMBL1025415,Antibacterial activity against exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818124,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104217,Dose-dependent effect,2661787,CHEMBL1025417,Bactericidal activity against high inoculum density stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104218,Active,2661788,CHEMBL1025418,Bactericidal activity against stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 17 hrs in MHBc at 32 ug/ml after 24 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104219,,2661789,CHEMBL1025419,Bactericidal activity against high inoculum density stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc assessed as log reduction in CFU per millimiter at 100 ug/mL after 8 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,=,1,0,=,Activity,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,3.0
104220,Not Active,2661795,CHEMBL1025421,Bactericidal activity against high inoculum density stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc at 10 ug/mL after 24 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104221,Active,2661796,CHEMBL1025423,Bactericidal activity against high inoculum density exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 10 ug/mL after 24 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104222,Active,2661797,CHEMBL1025424,Bactericidal activity against high inoculum density exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc assessed as log reduction in cell density at 100 ug/mL after 1 hr by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104223,Active,2661798,CHEMBL1025425,Bactericidal activity against high inoculum density stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc at 100 ug/mL after prolonged treatment period by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104224,,2661799,CHEMBL1025426,Bactericidal activity against stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc followed by dilution in nutrient depleted MHBc assessed as logarithmic reduction in CFU per millimiter at 10 ug/mL after 24 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,>,1,0,>,Activity,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,1.0
104225,Active,2661800,CHEMBL1025427,Bactericidal activity against CCCP-induced metabolically arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 10 ug/mL after 24 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104226,Active,2661802,CHEMBL1025428,Bactericidal activity against erythromycin-induced metabolically arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 10 ug/mL after 24 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104227,Active,2661805,CHEMBL1027060,Bactericidal activity against 1 hr cold-arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 2 ug/mL incubated at 0 degC by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104228,Active,2661807,CHEMBL1027061,Bactericidal activity against 24 hrs cold-arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 2 ug/mL incubated at 37 degC after 2 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104229,Active,2661810,CHEMBL1027062,Bactericidal activity against stationary phase culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for >17 hrs in MHBc followed by dilution in nutrient depleted MHBc assessed as logarithmic reduction in CFU per millimiter at 100 ug/mL after 24 hrs by time kill study,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818124,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104230,Not Active,2676209,CHEMBL1053791,Antibacterial activity against daptomycin-nonusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis assessed as inhibition on heterogeneous subpopulation survival rate at 0.5 and 4 ug/ml after 48 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104231,,2676210,CHEMBL1055372,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104232,,2676211,CHEMBL1055373,Antibacterial activity against daptomycin-transitional Staphylococcus aureus isolate 629 bloodstream form isolated from patient with endocarditis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.75
104233,,2676212,CHEMBL1055374,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient with endocarditis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104234,,2676213,CHEMBL1055375,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104235,,2676228,CHEMBL1053780,Antibacterial activity against Staphylococcus aureus SA113 by Etset,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.38
104236,,2676229,CHEMBL1053781,Antibacterial activity against Staphylococcus aureus SA113 harboring null mutation in mprF gene by Etset,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,1,=,MIC,ug.mL-1,0.094,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.094
104237,Not Active,2676234,CHEMBL1053788,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis assessed as inhibition on heterogeneous subpopulation survival rate at 0.5 and 1 ug/ml after 48 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104238,Not Active,2676235,CHEMBL1053789,Antibacterial activity against daptomycin-transitional Staphylococcus aureus isolate 629 bloodstream form isolated from patient with endocarditis assessed as inhibition on heterogeneous subpopulation survival rate at 0.5 and 1 ug/ml after 48 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104239,Not Active,2676236,CHEMBL1053790,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient with endocarditis assessed as inhibition on heterogeneous subpopulation survival rate at 0.5 and 4 ug/ml after 48 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104240,Active,2676237,CHEMBL1053792,Induction of cell membrane depolarization in methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis at 0.75 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104241,Active,2676238,CHEMBL1054575,Induction of cell membrane depolarization in methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis at 6 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104242,Not Active,2676239,CHEMBL1054572,Induction of cell membrane depolarization in daptomycin-transitional Staphylococcus aureus isolate 629 bloodstream form isolated from patient with endocarditis at 0.75 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104243,Not Active,2676240,CHEMBL1054573,Induction of cell membrane depolarization in daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient with endocarditis at 0.75 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104244,Not Active,2676241,CHEMBL1054574,Induction of cell membrane depolarization in daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis at 0.75 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104245,Not Active,2676242,CHEMBL1054576,Induction of cell membrane depolarization in daptomycin-transitional Staphylococcus aureus isolate 629 bloodstream form isolated from patient with endocarditis at 6 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104246,Not Active,2676243,CHEMBL1056202,Induction of cell membrane depolarization in daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient with endocarditis at 6 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104247,Not Active,2676244,CHEMBL1056203,Induction of cell membrane depolarization in daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis at 6 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104248,Not Active,2676245,CHEMBL1056204,Induction of cell membrane depolarization in methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis at 40 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104249,Not Active,2676246,CHEMBL1056204,Induction of cell membrane depolarization in methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis at 40 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104250,Not Active,2676247,CHEMBL1056205,Induction of cell membrane depolarization in daptomycin-transitional Staphylococcus aureus isolate 629 bloodstream form isolated from patient with endocarditis at 40 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104251,Not Active,2676248,CHEMBL1056206,Induction of cell membrane depolarization in daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient with endocarditis at 40 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104252,Not Active,2676249,CHEMBL1056207,Induction of cell membrane depolarization in daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis at 40 ug/ml after 60 mins by flow cytometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104253,Active,2676254,CHEMBL1056213,Reduction of membrane permeabilization in daptomycin-transitional Staphylococcus aureus isolate 629 bloodstream form isolated from patient with endocarditis assessed as calcein retention at 1.5 ug/ml after 120 mins by fluorometric analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104254,Active,2676255,CHEMBL1056214,Reduction of membrane permeabilization in daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient with endocarditis assessed as calcein retention at 1.5 ug/ml after 120 mins by fluorometric analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104255,Active,2676256,CHEMBL1056215,Reduction of membrane permeabilization in daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis assessed as calcein retention at 1.5 ug/ml after 120 mins by fluorometric analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104256,Not Active,2676257,CHEMBL1056212,Reduction of membrane permeabilization in methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis assessed as calcein retention at 1.5 ug/ml after 120 mins by fluorometric analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104257,Not Active,2676258,CHEMBL1056216,Induction of autolysis in daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient 6 ug/ml within 4 to 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104258,Not Active,2676259,CHEMBL1056217,Induction of autolysis in daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient 6 ug/ml within 4 to 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104259,Active,2676260,CHEMBL1056218,Induction of autolysis in methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient 6 ug/ml within 4 to 24 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,818608,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104260,,2676278,CHEMBL1054586,Drug binding to methicillin-susceptible Staphylococcus aureus isolate 616 bloodstream form isolated from patient with endocarditis at 6 ug after 10 mins by radial diffusion assay,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,0,=,Drug uptake,ug ml-1,5.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Drug uptake,ug ml-1,UO_0000274,5.4
104261,,2676279,CHEMBL1054587,Drug binding to daptomycin-transitional Staphylococcus aureus isolate 629 bloodstream form isolated from patient with endocarditis at 6 ug after 10 mins by radial diffusion assay,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,0,=,Drug uptake,ug ml-1,1.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Drug uptake,ug ml-1,UO_0000274,1.61
104262,,2676280,CHEMBL1054588,Drug binding to daptomycin-nonsusceptible Staphylococcus aureus isolate 701 bloodstream form isolated from patient with endocarditis at 6 ug after 10 mins by radial diffusion assay,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,0,=,Drug uptake,ug ml-1,2.32,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Drug uptake,ug ml-1,UO_0000274,2.32
104263,,2676281,CHEMBL1054589,Drug binding to daptomycin-nonsusceptible Staphylococcus aureus isolate 703 bloodstream form isolated from patient with endocarditis at 6 ug after 10 mins by radial diffusion assay,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151454,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818608,=,1,0,=,Drug uptake,ug ml-1,2.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Drug uptake,ug ml-1,UO_0000274,2.24
104264,,2679148,CHEMBL939743,Antibacterial activity against vancomycin-resistant Staphylococcus aureus HIP14300 isolated from patients foot wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819621,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104265,Not Determined,2679149,CHEMBL941479,Antibacterial activity against Enterococcus faecalis HIP14333 isolated from patients rectum by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,819621,,1,0,,MIC,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,,,
104266,,2679150,CHEMBL941480,Antibacterial activity against vancomycin-resistant Staphylococcus aureus HIP15178 isolated from patients surgical wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819621,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104267,,2679151,CHEMBL945596,Antibacterial activity against Enterococcus faecalis HIP15179 coisolated with vancomycin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819621,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
104268,,2679152,CHEMBL952610,Antibacterial activity against vancomycin-resistant Staphylococcus aureus AIS2006032 isolated from patients foot wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819621,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104269,,2679153,CHEMBL940631,Antibacterial activity against Enterococcus faecalis AIS2007003 isolated from patients rectum by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819621,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
104270,,2679154,CHEMBL1034671,Antibacterial activity against Enterococcus avium AIS2007004 isolated from patients rectum by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819621,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612354,Enterococcus avium,Enterococcus avium,33945.0,,MIC,ug ml-1,UO_0000274,1.0
104271,,2679155,CHEMBL1034672,Antibacterial activity against vancomycin-resistant Staphylococcus aureus AIS2006049 isolated from patients arm wound by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1151471,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819621,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104272,,2711643,CHEMBL1054957,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104273,,2711644,CHEMBL1054958,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104274,,2711645,CHEMBL1054959,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 harboring shuttle vector pYT3 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104275,,2711646,CHEMBL1054960,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 harboring shuttle vector pYT3 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104276,,2711647,CHEMBL1054961,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 harboring mutated graR gene after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104277,,2711648,CHEMBL1054962,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 harboring mutated graR gene after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104278,,2711649,CHEMBL1054963,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 harboring intact graR gene after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104279,,2711650,CHEMBL1054964,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus N315 harboring intact graR gene after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104280,,2711651,CHEMBL1054965,Antibacterial activity against graSR gene knockout vancomycin-susceptible Staphylococcus aureus N315 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104281,,2711652,CHEMBL1054966,Antibacterial activity against graSR gene knockout vancomycin-susceptible Staphylococcus aureus N315 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104282,,2711653,CHEMBL1054967,Antibacterial activity against mutated graR gene knockout vancomycin-susceptible Staphylococcus aureus N315 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104283,,2711654,CHEMBL1054968,Antibacterial activity against mutated graR gene knockout vancomycin-susceptible Staphylococcus aureus N315 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104284,,2711655,CHEMBL1054969,Antibacterial activity against mutated graSR gene knockout vancomycin-susceptible Staphylococcus aureus N315 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104285,,2711656,CHEMBL1057333,Antibacterial activity against mutated graSR gene knockout vancomycin-susceptible Staphylococcus aureus N315 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104286,,2711657,CHEMBL1057334,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104287,,2711658,CHEMBL1057335,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104288,,2711659,CHEMBL1057336,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 harboring shuttle vector pYT3 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104289,,2711660,CHEMBL1057337,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 harboring shuttle vector pYT3 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,2.0
104290,,2711661,CHEMBL1057338,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 harboring mutated graR gene after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104291,,2711662,CHEMBL1057339,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 harboring mutated graR gene after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104292,,2711663,CHEMBL1057340,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 harboring intact graR gene after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104293,,2711664,CHEMBL1057341,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 harboring intact graR gene after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104294,,2711665,CHEMBL1057342,Antibacterial activity against graSR gene knockout heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104295,,2711666,CHEMBL1057343,Antibacterial activity against graSR gene knockout heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.5
104296,,2711667,CHEMBL1057344,Antibacterial activity against mutated graR gene knockout heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104297,,2711668,CHEMBL1057345,Antibacterial activity against mutated graR gene knockout heterogeneous vancomycin-intermediate Staphylococcus aureus Mu3 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104298,,2711669,CHEMBL1057346,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104299,,2711670,CHEMBL1057347,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1152988,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826508,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,3.0
104300,Not Active,2723074,CHEMBL1053525,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by standard checkerboard method in presence of pulmonar surfactant and 50 mg/liter Ca2+,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,829540,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104301,Not Active,2723075,CHEMBL1053526,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by standard checkerboard method in presence of pulmonar surfactant and 50 mg/liter Ca2+,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,829540,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104302,,2723076,CHEMBL1056804,Ratio of antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 in presence of 1 mg/ml pulmonar surfactant and 50 mg/liter Ca2+ to antibacterial against methicillin-resistant Staphylococcus aureus ATCC 33591,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,829540,=,1,0,=,Ratio,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,32.0
104303,,2723077,CHEMBL1056805,Ratio of antibacterial activity against Streptococcus pneumoniae ATCC 49619 in presence of 1 mg/ml pulmonar surfactant and 50 mg/liter Ca2+ to antibacterial against Streptococcus pneumoniae ATCC 49619,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,829540,=,1,0,=,Ratio,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Ratio,,,128.0
104304,Active,3452449,CHEMBL1245564,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model at 6 mg/kg, ip over a period of 14 days",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104305,,3452450,CHEMBL1245411,"Antibacterial activity against 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,5.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,5.4
104306,,3452451,CHEMBL1245412,"Antibacterial activity against 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,3.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,3.6
104307,,3452452,CHEMBL1245413,"Antibacterial activity against 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,3.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,3.8
104308,,3452453,CHEMBL1245414,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,3.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,3.2
104309,,3452454,CHEMBL1245415,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 10 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.5
104310,,3452455,CHEMBL1245416,"Antibacterial activity against 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in blood at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.0
104311,,3452456,CHEMBL1245417,"Antibacterial activity against 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in spleen at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.2
104312,,3452457,CHEMBL1245418,"Antibacterial activity against 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in liver at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,1.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,1.8
104313,Active,3452458,CHEMBL1245419,"Antibacterial activity against 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104314,Active,3452459,CHEMBL1245420,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 3 dayss post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104315,Active,3452460,CHEMBL1245421,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104316,Active,3452461,CHEMBL1245422,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 10 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104317,,3452462,CHEMBL1245565,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as survival rate at 6 mg/kg, ip qd beginning 2 days post infection measured after 3 days post infection",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,951284,=,1,0,=,Activity,%,70.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,70.0
104318,,3452463,CHEMBL1245566,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as survival rate at 20 mg/kg, ip qd beginning 2 days post infection measured after 3 days post infection",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,951284,=,1,0,=,Activity,%,60.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,60.0
104319,,3452464,CHEMBL1245423,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,6.0
104320,,3452465,CHEMBL1245424,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,4.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,4.2
104321,,3452466,CHEMBL1245425,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,3.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,3.5
104322,,3452467,CHEMBL1245426,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.2
104323,,3452468,CHEMBL1245427,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 10 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.9
104324,,3452469,CHEMBL1245429,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in blood at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.6
104325,,3452470,CHEMBL1245430,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in blood at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,0.1
104326,,3452471,CHEMBL1245431,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in spleen at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,1.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,1.4
104327,,3452472,CHEMBL1245432,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in spleen at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,0.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,0.4
104328,,3452473,CHEMBL1245433,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in liver at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,1.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,1.2
104329,Active,3452474,CHEMBL1245434,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremiar at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104330,Active,3452475,CHEMBL1245435,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104331,Active,3452476,CHEMBL1245436,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 10 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104332,,3452480,CHEMBL1245567,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in therapeutic C57BL/6 mouse model assessed as survival rate at 6 mg/kg, ip qd beginning at time of infection measured after 6 days post infection",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,951284,=,1,0,=,Activity,%,40.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,40.0
104333,Active,3452481,CHEMBL1245444,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104334,,3452486,CHEMBL1245437,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,5.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,5.5
104335,,3452487,CHEMBL1245438,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 4 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.9
104336,,3452488,CHEMBL1245439,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.8
104337,,3452489,CHEMBL1245440,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as bacterial count in blood at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.3
104338,,3452490,CHEMBL1245441,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as bacterial count in blood at 6 mg/kg, ip measured after 4 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,2.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,2.6
104339,,3452491,CHEMBL1245446,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,6.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,6.3
104340,,3452492,CHEMBL1245447,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,5.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,5.5
104341,,3452493,CHEMBL1245448,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,5.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,5.5
104342,,3452494,CHEMBL1245449,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,3.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,3.5
104343,Active,3452495,CHEMBL1245450,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacteremic mouse at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104344,Active,3452496,CHEMBL1245451,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacteremic mouse at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104345,Active,3452497,CHEMBL1245452,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacteremic mouse at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104346,Active,3452498,CHEMBL1245453,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacteremic mouse at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104347,Active,3452499,CHEMBL1245454,"Antibacterial activity against low dose 5 x 10'6 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacteremic mouse at 6 mg/kg, ip measured after 10 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104348,,3452500,CHEMBL1245455,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,6.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,6.4
104349,,3452501,CHEMBL1245456,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,6.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,6.2
104350,,3452502,CHEMBL1245457,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,7.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,7.1
104351,,3452503,CHEMBL1245458,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 4 days post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,4.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,4.5
104352,,3452504,CHEMBL1245459,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacterial count in lung at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,=,1,0,=,log10cfu,,4.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10cfu,,,4.7
104353,Active,3452505,CHEMBL1245461,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 1 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104354,Active,3452506,CHEMBL1245462,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 2 days post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104355,Active,3452507,CHEMBL1245463,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as reduction of bacteremia at 6 mg/kg, ip measured after 3 days post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104356,Active,3452508,CHEMBL1245464,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacteremic mice at 6 mg/kg, ip measured after 4 days post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104357,Active,3452509,CHEMBL1245465,"Antibacterial activity against high dose 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in semitherapeutic C57BL/6 mouse model assessed as bacteremic mice at 6 mg/kg, ip measured after 5 day post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104358,Active,3452513,CHEMBL1245570,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in therapeutic C57BL/6 mouse model assessed as effect on leukocytes infiltration in BALF at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104359,Active,3452514,CHEMBL1245571,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as effect on leukocytes infiltration in BALF at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104360,Active,3452515,CHEMBL1245568,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in therapeutic C57BL/6 mouse model assessed as effect on lung permeability at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104361,Active,3452516,CHEMBL1245569,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as effect on lung permeability at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104362,Active,3452517,CHEMBL1245572,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in therapeutic C57BL/6 mouse model assessed as increase in compound level in BALF at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104363,Not Active,3452518,CHEMBL1245573,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as increase in compound level in BALF at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104364,Active,3452519,CHEMBL1245574,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 19 infected in therapeutic C57BL/6 mouse model assessed as increase in serum compound level at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104365,Active,3452520,CHEMBL1245575,"Antibacterial activity against 1.5 x 10'7 CFU Streptococcus pneumoniae serotype 2 infected in therapeutic C57BL/6 mouse model assessed as increase in serum compound level at 6 mg/kg, ip measured on day 3 post infection",F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1240356,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,951284,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104366,,3476758,CHEMBL1262332,Antimicrobial activity against Staphylococcus aureus 2546,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958125,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104367,,3476759,CHEMBL1262333,Antimicrobial activity against Staphylococcus aureus 2547 small colony variants,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958125,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104368,,3476760,CHEMBL1262334,Antimicrobial activity against Staphylococcus aureus 2548,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958125,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104369,,3476761,CHEMBL1262335,Antimicrobial activity against Staphylococcus aureus 2549 small colony variants,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958125,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104370,Active,3476782,CHEMBL1262337,Antimicrobial activity against extracellular Staphylococcus aureus 2546 after 4 hrs in MH-II broth,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958125,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104371,Active,3476783,CHEMBL1262338,Antimicrobial activity against extracellular Staphylococcus aureus 2548 after 4 hrs in MH-II broth,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958125,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104372,Active,3476784,CHEMBL1262339,Antimicrobial activity against extracellular Staphylococcus aureus 2549 small colony variants after 4 hrs in MH-II broth,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958125,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104373,Active,3476790,CHEMBL1262336,Antimicrobial activity against intracellular Staphylococcus aureus 2548 infected in human monocyte-derived macrophages after 48 hrs,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255343,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958125,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104374,,3478043,CHEMBL1267613,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958143,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104375,,3478044,CHEMBL1267614,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as decrease in cell viability at 4 ug/ml within 120 mins,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958143,>,1,0,>,FC,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,1000.0
104376,Not Active,3478045,CHEMBL1267620,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as cell lysis at 4 ug/ml after 120 mins,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958143,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104377,,3478046,CHEMBL1267621,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as cell lysis at MIC after 120 mins,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958143,=,1,0,=,Activity,%,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,50.0
104378,,3478047,CHEMBL1267615,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as decrease in cell viability at MIC after 120 mins,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958143,=,1,0,=,FC,,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,200.0
104379,Not Active,3478048,CHEMBL1267616,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as cell lysis at 4 ug/ml after 60 mins by transmission electron microscopy,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958143,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104380,,3478049,CHEMBL1267617,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as altered cell morphology at 4 ug/ml after 60 mins by transmission electron microscopy,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958143,>,1,0,>,Activity,%,90.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,90.0
104381,Not Active,3478050,CHEMBL1267618,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as calcein release at 4 ug/ml,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958143,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104382,Not Active,3478051,CHEMBL1267619,Bactericidal activity against Staphylococcus aureus ATCC 29213 assessed as membrane permeability at 4 ug/ml by ToPro3 dye based assay,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255360,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958143,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104383,,3478566,CHEMBL1266054,Antimicrobial activity against beta-lactam resistant Streptococcus pneumoniae clinical isolate by broth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958471,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.06
104384,,3478567,CHEMBL1266054,Antimicrobial activity against beta-lactam resistant Streptococcus pneumoniae clinical isolate by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958471,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.06
104385,,3478586,CHEMBL1266054,Antimicrobial activity against beta-lactam resistant Streptococcus pneumoniae clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255371,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958471,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
104386,,3479248,CHEMBL1268277,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus capitis isolate 1285355 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC,ug ml-1,UO_0000274,1.0
104387,,3479249,CHEMBL1268276,Antibacterial activity against daptomycin-nonsusceptible coagulase-negative Staphylococcus isolate 1285835 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,1.0
104388,,3479250,CHEMBL1268275,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1585404 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104389,,3479251,CHEMBL1268274,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1176127 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104390,,3479252,CHEMBL1268273,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1171063 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104391,,3479253,CHEMBL1267830,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1171055 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104392,,3479254,CHEMBL1267826,Antibacterial activity against Streptococcus sp. clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC,ug ml-1,UO_0000274,0.03
104393,,3479255,CHEMBL1267826,Antibacterial activity against Streptococcus sp. clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC90,ug ml-1,UO_0000274,1.0
104394,,3479256,CHEMBL1267826,Antibacterial activity against Streptococcus sp. clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC50,ug ml-1,UO_0000274,0.25
104395,,3479257,CHEMBL1267825,Antibacterial activity against Streptococcus sanguinis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC,ug ml-1,UO_0000274,0.03
104396,,3479258,CHEMBL1267825,Antibacterial activity against Streptococcus sanguinis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC90,ug ml-1,UO_0000274,1.0
104397,,3479259,CHEMBL1267825,Antibacterial activity against Streptococcus sanguinis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC50,ug ml-1,UO_0000274,0.25
104398,,3479260,CHEMBL1267824,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,0.03
104399,,3479261,CHEMBL1267824,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC90,ug ml-1,UO_0000274,1.0
104400,,3479262,CHEMBL1267824,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC50,ug ml-1,UO_0000274,0.25
104401,,3479263,CHEMBL1267823,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.03
104402,,3479264,CHEMBL1267823,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC90,ug ml-1,UO_0000274,1.0
104403,,3479265,CHEMBL1267823,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC50,ug ml-1,UO_0000274,0.25
104404,,3479266,CHEMBL1267822,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC,ug ml-1,UO_0000274,0.03
104405,,3479267,CHEMBL1267822,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC90,ug ml-1,UO_0000274,1.0
104406,,3479268,CHEMBL1267822,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC50,ug ml-1,UO_0000274,0.25
104407,,3479269,CHEMBL1267821,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC,ug ml-1,UO_0000274,0.03
104408,,3479270,CHEMBL1267821,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC90,ug ml-1,UO_0000274,1.0
104409,,3479271,CHEMBL1267821,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC50,ug ml-1,UO_0000274,0.25
104410,,3479272,CHEMBL1267820,Antibacterial activity against Streptococcus bovis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>=,1,1,>=,MIC,ug.mL-1,0.03,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC,ug ml-1,UO_0000274,0.03
104411,,3479273,CHEMBL1267820,Antibacterial activity against Streptococcus bovis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC90,ug ml-1,UO_0000274,1.0
104412,,3479274,CHEMBL1267820,Antibacterial activity against Streptococcus bovis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC50,ug ml-1,UO_0000274,0.25
104413,,3479275,CHEMBL1267819,Antibacterial activity against Streptococcus sp. Group G clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
104414,,3479276,CHEMBL1267819,Antibacterial activity against Streptococcus sp. Group G clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
104415,,3479277,CHEMBL1267819,Antibacterial activity against Streptococcus sp. Group G clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.06
104416,,3479278,CHEMBL1267818,Antibacterial activity against Streptococcus sp. Group F clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC,ug ml-1,UO_0000274,0.03
104417,,3479279,CHEMBL1267818,Antibacterial activity against Streptococcus sp. Group F clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC90,ug ml-1,UO_0000274,0.25
104418,,3479280,CHEMBL1267818,Antibacterial activity against Streptococcus sp. Group F clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC50,ug ml-1,UO_0000274,0.06
104419,,3479281,CHEMBL1267817,Antibacterial activity against Streptococcus sp. Group C clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
104420,,3479282,CHEMBL1267817,Antibacterial activity against Streptococcus sp. Group C clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
104421,,3479283,CHEMBL1267817,Antibacterial activity against Streptococcus sp. Group C clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.06
104422,,3479284,CHEMBL1267816,Antibacterial activity against Streptococcus agalactiae clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.12
104423,,3479285,CHEMBL1267816,Antibacterial activity against Streptococcus agalactiae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,0.25
104424,,3479286,CHEMBL1267816,Antibacterial activity against Streptococcus agalactiae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.25
104425,,3479287,CHEMBL1267815,Antibacterial activity against Streptococcus pyogenes clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.03
104426,,3479288,CHEMBL1267815,Antibacterial activity against Streptococcus pyogenes clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.06
104427,,3479289,CHEMBL1267815,Antibacterial activity against Streptococcus pyogenes clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.06
104428,,3479290,CHEMBL1267776,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
104429,,3479291,CHEMBL1267776,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
104430,,3479292,CHEMBL1267776,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,2.0
104431,,3479293,CHEMBL1267775,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.25
104432,,3479294,CHEMBL1267775,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
104433,,3479295,CHEMBL1267775,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,2.0
104434,,3479296,CHEMBL1267774,Antibacterial activity against vancomycin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,<=,1,1,<=,MIC,ug.mL-1,0.015,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.015
104435,,3479297,CHEMBL1267774,Antibacterial activity against vancomycin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
104436,,3479298,CHEMBL1267774,Antibacterial activity against vancomycin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,2.0
104437,,3479299,CHEMBL1267773,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
104438,,3479300,CHEMBL1267772,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
104439,,3479301,CHEMBL1267772,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,1.0
104440,,3479302,CHEMBL1267772,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,0.5
104441,,3479303,CHEMBL1267771,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.12
104442,,3479304,CHEMBL1267771,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,1.0
104443,,3479305,CHEMBL1267771,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
104444,,3479306,CHEMBL1267770,Antibacterial activity against methicillin-resistant coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.12
104445,,3479307,CHEMBL1267770,Antibacterial activity against methicillin-resistant coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,1.0
104446,,3479308,CHEMBL1267770,Antibacterial activity against methicillin-resistant coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.5
104447,,3479309,CHEMBL1267769,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,MIC,ug ml-1,UO_0000274,0.12
104448,,3479310,CHEMBL1267769,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,MIC90,ug ml-1,UO_0000274,1.0
104449,,3479311,CHEMBL1267769,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,MIC50,ug ml-1,UO_0000274,0.5
104450,,3479312,CHEMBL1267768,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC,ug ml-1,UO_0000274,0.12
104451,,3479313,CHEMBL1267768,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC90,ug ml-1,UO_0000274,1.0
104452,,3479314,CHEMBL1267768,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC50,ug ml-1,UO_0000274,0.5
104453,,3479315,CHEMBL1267767,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC,ug ml-1,UO_0000274,0.12
104454,,3479316,CHEMBL1267767,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC90,ug ml-1,UO_0000274,1.0
104455,,3479317,CHEMBL1267767,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC50,ug ml-1,UO_0000274,0.5
104456,,3479318,CHEMBL1267766,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC,ug ml-1,UO_0000274,0.12
104457,,3479319,CHEMBL1267766,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC90,ug ml-1,UO_0000274,1.0
104458,,3479320,CHEMBL1267766,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC50,ug ml-1,UO_0000274,0.5
104459,,3479321,CHEMBL1267765,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.12
104460,,3479322,CHEMBL1267765,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,1.0
104461,,3479323,CHEMBL1267765,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,0.5
104462,,3479324,CHEMBL1267764,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.12
104463,,3479325,CHEMBL1267764,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,1.0
104464,,3479326,CHEMBL1267764,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,0.5
104465,,3479327,CHEMBL1267763,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.12
104466,,3479328,CHEMBL1267763,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,1.0
104467,,3479329,CHEMBL1267763,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,0.5
104468,,3479330,CHEMBL1267762,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
104469,,3479331,CHEMBL1267762,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,1.0
104470,,3479332,CHEMBL1267762,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.5
104471,,3479333,CHEMBL1267761,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC,ug ml-1,UO_0000274,0.12
104472,,3479334,CHEMBL1267761,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC90,ug ml-1,UO_0000274,1.0
104473,,3479335,CHEMBL1267761,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC50,ug ml-1,UO_0000274,0.5
104474,,3479336,CHEMBL1267760,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC,ug ml-1,UO_0000274,0.12
104475,,3479337,CHEMBL1267760,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC90,ug ml-1,UO_0000274,1.0
104476,,3479338,CHEMBL1267760,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC50,ug ml-1,UO_0000274,0.5
104477,,3479339,CHEMBL1267759,Antibacterial activity against methicillin-susceptible coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.12
104478,,3479340,CHEMBL1267759,Antibacterial activity against methicillin-susceptible coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,1.0
104479,,3479341,CHEMBL1267759,Antibacterial activity against methicillin-susceptible coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.5
104480,,3479342,CHEMBL1267758,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,MIC,ug ml-1,UO_0000274,0.12
104481,,3479343,CHEMBL1267758,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,MIC90,ug ml-1,UO_0000274,1.0
104482,,3479344,CHEMBL1267758,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,MIC50,ug ml-1,UO_0000274,0.5
104483,,3479345,CHEMBL1267757,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC,ug ml-1,UO_0000274,0.12
104484,,3479346,CHEMBL1267757,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC90,ug ml-1,UO_0000274,1.0
104485,,3479347,CHEMBL1267757,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC50,ug ml-1,UO_0000274,0.5
104486,,3479348,CHEMBL1267756,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC,ug ml-1,UO_0000274,0.12
104487,,3479349,CHEMBL1267756,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC90,ug ml-1,UO_0000274,1.0
104488,,3479350,CHEMBL1267756,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,MIC50,ug ml-1,UO_0000274,0.5
104489,,3479351,CHEMBL1267755,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC,ug ml-1,UO_0000274,0.12
104490,,3479352,CHEMBL1267755,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC90,ug ml-1,UO_0000274,1.0
104491,,3479353,CHEMBL1267755,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,MIC50,ug ml-1,UO_0000274,0.5
104492,,3479354,CHEMBL1267754,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.12
104493,,3479355,CHEMBL1267754,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,1.0
104494,,3479356,CHEMBL1267754,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,0.5
104495,,3479357,CHEMBL1267753,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.12
104496,,3479358,CHEMBL1267753,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,1.0
104497,,3479359,CHEMBL1267753,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,0.5
104498,,3479360,CHEMBL1267752,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.12
104499,,3479361,CHEMBL1267752,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,1.0
104500,,3479362,CHEMBL1267752,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,0.5
104501,,3479363,CHEMBL1267751,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.12
104502,,3479364,CHEMBL1267751,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,1.0
104503,,3479365,CHEMBL1267751,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.5
104504,,3479366,CHEMBL1267750,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC,ug ml-1,UO_0000274,0.12
104505,,3479367,CHEMBL1267750,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC90,ug ml-1,UO_0000274,1.0
104506,,3479368,CHEMBL1267750,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,MIC50,ug ml-1,UO_0000274,0.5
104507,,3479369,CHEMBL1267749,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC,ug ml-1,UO_0000274,0.12
104508,,3479370,CHEMBL1267749,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC90,ug ml-1,UO_0000274,1.0
104509,,3479371,CHEMBL1267749,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC50,ug ml-1,UO_0000274,0.5
104510,,3479372,CHEMBL1267748,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,>,1,1,>,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
104511,,3479373,CHEMBL1267748,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104512,,3479374,CHEMBL1267748,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104513,,3479375,CHEMBL1267747,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
104514,,3479376,CHEMBL1267747,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104515,,3479377,CHEMBL1267747,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958673,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104516,,3481146,CHEMBL1265103,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 510 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104517,,3481147,CHEMBL1264924,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 557 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104518,,3481148,CHEMBL1264925,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 509 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104519,,3481149,CHEMBL1264926,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 1263 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104520,,3481150,CHEMBL1264927,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 1264 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104521,,3481151,CHEMBL1264928,Antibacterial activity against vancomycin-hetero-intermediate Staphylococcus aureus isolate 618 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104522,,3481152,CHEMBL1264929,Antibacterial activity against vancomycin-hetero-intermediate Staphylococcus aureus isolate 873 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104523,,3481153,CHEMBL1264930,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 555 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104524,,3481154,CHEMBL1264931,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1287 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104525,,3481155,CHEMBL1264932,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 770 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104526,,3481156,CHEMBL1264933,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1008 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104527,,3481157,CHEMBL1264934,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1009 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104528,,3481158,CHEMBL1264935,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1010 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104529,,3481159,CHEMBL1264936,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1011 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104530,,3481160,CHEMBL1264937,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1012 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104531,,3481161,CHEMBL1264938,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1013 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104532,,3481162,CHEMBL1264939,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1014 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104533,,3481163,CHEMBL1264940,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1015 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104534,,3481164,CHEMBL1265068,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1016 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104535,,3481165,CHEMBL1265069,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1017 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104536,,3481166,CHEMBL1265070,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 511 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104537,,3481167,CHEMBL1265071,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1003 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104538,,3481168,CHEMBL1265072,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1004 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104539,,3481169,CHEMBL1265073,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1005 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104540,,3481170,CHEMBL1265074,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1006 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104541,,3481171,CHEMBL1265075,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1984 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104542,,3481172,CHEMBL1265076,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus isolate 1007 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104543,,3481173,CHEMBL1265077,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2003 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104544,,3481174,CHEMBL1265078,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1743 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104545,,3481175,CHEMBL1265079,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1751 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104546,,3481176,CHEMBL1265080,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1766 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104547,,3481177,CHEMBL1265081,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1776 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104548,,3481178,CHEMBL1265082,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1806 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104549,,3481179,CHEMBL1265083,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1808 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104550,,3481180,CHEMBL1265084,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1838 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104551,,3481181,CHEMBL1265085,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1851 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104552,,3481182,CHEMBL1265086,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus isolate 1867 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104553,,3481183,CHEMBL1265087,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 1468 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104554,,3481184,CHEMBL1265088,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 1469 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104555,,3481185,CHEMBL1265089,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 815 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104556,,3481186,CHEMBL1265090,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 950 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104557,,3481187,CHEMBL1265091,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 1471 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104558,,3481188,CHEMBL1265092,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 1472 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104559,,3481189,CHEMBL1265093,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 593 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104560,,3481955,CHEMBL1265094,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 693 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104561,,3481956,CHEMBL1265095,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-positive Staphylococcus aureus isolate 813 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104562,,3481957,CHEMBL1265096,Antibacterial activity against community-acquired methicillin-resistant panton-valentine leukocidin-negative Staphylococcus aureus isolate 1470 after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104563,,3482056,CHEMBL1264589,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104564,,3482057,CHEMBL1264590,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104565,,3482058,CHEMBL1264591,Antibacterial activity against vancomycin-hetero-intermediate Staphylococcus aureus after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104566,,3482059,CHEMBL1264727,Antibacterial activity against vancomycin-resistant Staphylococcus aureus after 24 hrs by modified broth macrodilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255424,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959785,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104567,,3483008,CHEMBL1268781,"Antimicrobial activity against Streptococcus pneumoniae serotype 3 clinical isolate infected in Wistar rat assessed as cerebrospinal fluid bacterial titer at 50 mg/kg, sc administered 18 hrs post infection measured after 4 hrs",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255397,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,959536,<,1,0,<,log10CFU/ml,,1000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,log10CFU/ml,,,1000.0
104568,Toxic,3483010,CHEMBL1267545,"Toxicity in against Streptococcus pneumoniae serotype 3 clinical isolate infected in Wistar rat assessed as increase in CSF IL-18 concentration at 100 mg/kg, sc administered 18 hrs post infection measured after 2 to 6 hrs by microsphere-based multiplex assay",T,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255397,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,959536,,1,0,,Activity,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,,,
104569,,3483011,CHEMBL1268783,"Decrease in severity of cortical damage in Streptococcus pneumoniae serotype 3 clinical isolate infected in Wistar rat at 50 mg/kg, sc administered 18 hrs post infection measured after 2 to 6 hrs",F,BAO_0000201,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255397,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,959536,=,1,1,=,Inhibition,%,0.13,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,INH,%,UO_0000187,0.13
104570,Non-toxic,3483018,CHEMBL1268786,"Toxicity in Streptococcus pneumoniae serotype 3 clinical isolate infected in Wistar rat assessed as decrease in CSF IL-6 concentration at 50 mg/kg, sc administered 18 hrs post infection measured after 2 to 6 hrs by microsphere-based multiplex assay",T,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255397,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,959536,,1,0,,Activity,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,,,
104571,Non-toxic,3483019,CHEMBL1268785,"Toxicity in Streptococcus pneumoniae serotype 3 clinical isolate infected in Wistar rat assessed as decrease in CSF CXCL1 concentration at 50 mg/kg, sc administered 18 hrs post infection measured after 2 to 6 hrs by microsphere-based multiplex assay",T,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255397,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,959536,,1,0,,Activity,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,,,
104572,Non-toxic,3483020,CHEMBL1268784,"Toxicity in Streptococcus pneumoniae serotype 3 clinical isolate infected in Wistar rat assessed as decrease in CSF TNF-alpha concentration at 50 mg/kg, sc administered 18 hrs post infection measured after 2 to 6 hrs by microsphere-based multiplex assay",T,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255397,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,959536,,1,0,,Activity,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,Activity,,,
104573,Active,3484421,CHEMBL1268182,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958181,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104574,,3484424,CHEMBL1268574,Antimicrobial activity against Linezolid and methicillin-resistant coagulase-negative Staphylococcus by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.5
104575,,3484431,CHEMBL1268043,Antimicrobial activity against linezolid-susceptible Staphylococcus aureus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104576,,3484435,CHEMBL1268043,Antimicrobial activity against linezolid-susceptible Staphylococcus aureus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104577,,3484439,CHEMBL1268044,Antimicrobial activity against linezolid-susceptible Staphylococcus aureus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104578,,3484444,CHEMBL1268045,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104579,,3484449,CHEMBL1268045,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104580,,3484453,CHEMBL1268046,Antimicrobial activity against oxacillin-susceptible Staphylococcus aureus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104581,,3484458,CHEMBL1268047,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104582,,3484463,CHEMBL1268047,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104583,,3484467,CHEMBL1268048,Antimicrobial activity against oxacillin-resistant Staphylococcus aureus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104584,,3484472,CHEMBL1268049,Antimicrobial activity against linezolid-resistant Staphylococcus aureus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104585,,3484476,CHEMBL1268050,Antimicrobial activity against linezolid-resistant Staphylococcus aureus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104586,,3484481,CHEMBL1268051,Antimicrobial activity against linezolid-susceptible coagulase-negative Staphylococcus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.25
104587,,3484486,CHEMBL1268051,Antimicrobial activity against linezolid-susceptible coagulase-negative Staphylococcus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,0.5
104588,,3484490,CHEMBL1268052,Antimicrobial activity against linezolid-susceptible coagulase-negative Staphylococcus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,Activity,%,UO_0000187,100.0
104589,,3484495,CHEMBL1268060,Antimicrobial activity against oxacillin-susceptible coagulase-negative Staphylococcus aureus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104590,,3484500,CHEMBL1268060,Antimicrobial activity against oxacillin-susceptible coagulase-negative Staphylococcus aureus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104591,,3484504,CHEMBL1268061,Antimicrobial activity against oxacillin-susceptible coagulase-negative Staphylococcus aureus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104592,,3484509,CHEMBL1268062,Antimicrobial activity against oxacillin-resistant coagulase-negative Staphylococcus aureus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104593,,3484514,CHEMBL1268062,Antimicrobial activity against oxacillin-resistant coagulase-negative Staphylococcus aureus by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104594,,3484518,CHEMBL1268063,Antimicrobial activity against oxacillin-resistant coagulase-negative Staphylococcus aureus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104595,,3484523,CHEMBL1268064,Antimicrobial activity against linezolid-resistant coagulase-negative Staphylococcus by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958181,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.5
104596,,3484527,CHEMBL1268065,Antimicrobial activity against linezolid-resistant coagulase-negative Staphylococcus assessed as percent susceptible strain by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255438,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958181,=,1,0,=,Activity,%,100.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,Activity,%,UO_0000187,100.0
104597,,3492579,CHEMBL1264349,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 616,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957965,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.125
104598,,3492580,CHEMBL1265163,AUC(0-24 hrs)/MIC(broth) in methicillin-susceptible Staphylococcus aureus 616 at 1 g administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,RatioAUC/MIC,,536.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,536.4
104599,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492581,CHEMBL1265162,Cmax in methicillin-susceptible Staphylococcus aureus 616 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,65897.86,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,106.8
104600,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492582,CHEMBL1265161,Cmin in methicillin-susceptible Staphylococcus aureus 616 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,9810.64,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,15.9
104601,,3492583,CHEMBL1265160,Half life in methicillin-susceptible Staphylococcus aureus 616 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,957965,=,1,1,=,T1/2,hr,8.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,8.4
104602,,3492584,CHEMBL1265159,AUC(0-24 hrs)/MIC(broth) in methicillin-susceptible Staphylococcus aureus 616 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,10005.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,10005.9
104603,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492585,CHEMBL1265158,Cmax in methicillin-susceptible Staphylococcus aureus 616 at 10 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,98846.79,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,160.2
104604,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492586,CHEMBL1265157,Cmin in methicillin-susceptible Staphylococcus aureus 616 at 10 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,15734.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,25.5
104605,,3492587,CHEMBL1265156,Half life in methicillin-susceptible Staphylococcus aureus 616 at 10 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,957965,=,1,1,=,T1/2,hr,9.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,9.3
104606,,3492588,CHEMBL1265155,AUC(0-24 hrs)/MIC(broth) in methicillin-susceptible Staphylococcus aureus 616 at 10 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,14480.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,14480.8
104607,,3492592,CHEMBL1265152,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 675,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957965,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
104608,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492593,CHEMBL1265149,Cmax in methicillin-resistant Staphylococcus aureus 675 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,66144.67,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,107.2
104609,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492594,CHEMBL1265148,Cmin in methicillin-resistant Staphylococcus aureus 675 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,8700.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,14.1
104610,,3492595,CHEMBL1265147,Half life in methicillin-resistant Staphylococcus aureus 675 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,957965,=,1,1,=,T1/2,hr,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,8.0
104611,,3492596,CHEMBL1265145,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus 675 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,4990.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4990.2
104612,,3492601,CHEMBL1265313,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 36132,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957965,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
104613,,3492602,CHEMBL1265142,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus 36132 at 1 g administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,257.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,257.4
104614,,3492603,CHEMBL1265151,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus 675 at 1 g administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,277.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,277.1
104615,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492604,CHEMBL1265141,Cmax in methicillin-resistant Staphylococcus aureus 36132 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,67440.41,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,109.3
104616,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492605,CHEMBL1265140,Cmin in methicillin-resistant Staphylococcus aureus 36132 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,10674.47,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,17.3
104617,,3492606,CHEMBL1265139,Half life in methicillin-resistant Staphylococcus aureus 36132 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,957965,=,1,1,=,T1/2,hr,8.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,8.8
104618,,3492607,CHEMBL1265138,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus 36132 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,5003.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,5003.6
104619,,3492608,CHEMBL1264362,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus WB1 at 1 g administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,271.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,271.8
104620,,3492609,CHEMBL1264358,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus WB1 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,4689.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4689.8
104621,,3492610,CHEMBL1264354,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus WB2 at 1 g administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,243.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,243.3
104622,,3492611,CHEMBL1264350,AUC(0-24 hrs)/MIC(broth) in methicillin-resistant Staphylococcus aureus WB2 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,957965,=,1,0,=,Ratio,,5643.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,5643.5
104623,,3492616,CHEMBL1265314,Antimicrobial activity against methicillin-resistant Staphylococcus aureus WB1,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957965,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
104624,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492617,CHEMBL1264361,Cmax in methicillin-resistant Staphylococcus aureus WB1 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,60653.18,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,98.3
104625,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492618,CHEMBL1264360,Cmin in methicillin-resistant Staphylococcus aureus WB1 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,7836.17,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,12.7
104626,,3492619,CHEMBL1264355,Half life in methicillin-resistant Staphylococcus aureus WB2 at 1 g administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,957965,=,1,1,=,T1/2,hr,7.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,7.9
104627,,3492624,CHEMBL1265315,Antimicrobial activity against methicillin-resistant Staphylococcus aureus WB2,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,957965,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
104628,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492625,CHEMBL1264353,Cmax in methicillin-resistant Staphylococcus aureus WB2 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,65465.94,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,106.1
104629,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3492626,CHEMBL1264352,Cmin in methicillin-resistant Staphylococcus aureus WB2 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,957965,=,1,1,=,Cmax,nM,7651.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Cmax,mg/L,UO_0000065,12.4
104630,,3492627,CHEMBL1264351,Half life in methicillin-resistant Staphylococcus aureus WB2 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,957965,=,1,1,=,T1/2,hr,7.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,7.6
104631,,3492642,CHEMBL1264359,Half life in methicillin-resistant Staphylococcus aureus WB1 at 6 mg/kg administered daily for 4 days pretreated with 1 g vancomycin administered every 12 hrs for 4 days in in vitro pharmacokinetic-pharmacodynamic model with simulated endocardial vegetations,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255234,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,957965,=,1,1,=,T1/2,hr,7.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,7.9
104632,,3492757,CHEMBL1262602,Antimicrobial activity against Enterococcus faecium isolate 2 from skin lesion of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
104633,,3492758,CHEMBL1262603,Antimicrobial activity against Enterococcus faecium isolate 3 from abdominal wound of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
104634,,3492759,CHEMBL1262604,Antimicrobial activity against Enterococcus faecium isolate 4 from lower extremity wound of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
104635,,3492760,CHEMBL1262605,Antimicrobial activity against Enterococcus faecium isolate 5 from patient blood by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
104636,,3492761,CHEMBL1262606,Antimicrobial activity against Enterococcus faecium isolate 6 from thigh wound of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
104637,,3492762,CHEMBL1262607,Antimicrobial activity against Enterococcus faecium isolate 7 from right abdominal wound of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
104638,,3492763,CHEMBL1262608,Antimicrobial activity against Enterococcus faecium isolate 8 from abdominal wound of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
104639,,3492764,CHEMBL1262610,Antimicrobial activity against Enterococcus faecium isolate 1 from right groin wound of patient by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
104640,,3492765,CHEMBL1262609,Antimicrobial activity against Staphylococcus aureus ATCC 29213 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104641,,3492766,CHEMBL1262611,Antimicrobial activity against Enterococcus faecium ATCC 35667 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255266,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958467,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,1.0
104642,,3492969,CHEMBL1262782,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958660,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104643,,3492981,CHEMBL1262782,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958660,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104644,,3492993,CHEMBL1262782,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958660,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104645,,3494058,CHEMBL1262783,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL gene and mec type IV gene assessed as susceptible strains by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958660,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104646,,3494067,CHEMBL1262784,Antimicrobial activity against community-acquired methicillin resistant Staphylococcus aureus expressing PVL and mec type IV gene assessed as resistant strains by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255268,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958660,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104647,,3496188,CHEMBL1263989,Antimicrobial activity against Listeria monocytogenes isolated from cerebrospinal fluid of meningitis patient by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255312,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959514,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,mg/L,UO_0000274,1.0
104648,,3496189,CHEMBL1263989,Antimicrobial activity against Listeria monocytogenes isolated from cerebrospinal fluid of meningitis patient by broth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255312,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959514,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC90,mg/L,UO_0000274,4.0
104649,,3496190,CHEMBL1263990,Antimicrobial activity against Listeria monocytogenes isolated from cerebrospinal fluid of meningitis patient by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255312,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959514,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC90,mg/L,UO_0000274,4.0
104650,,3496191,CHEMBL1263990,Antimicrobial activity against Listeria monocytogenes isolated from cerebrospinal fluid of meningitis patient by Etest method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255312,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,959514,=,1,0,=,MIC95,mg/L,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC95,mg/L,,1.0
104651,,3496192,CHEMBL1263987,Antimicrobial activity against Staphylococcus aureus infected in hydrocephalic rabbit administered intraventricularly as single dose,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255312,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959514,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.25
104652,,3496193,CHEMBL1263988,"Antimicrobial activity against penicillin-, quinolone-resistant Streptococcus pneumoniae WB4 infected in experimental rabbit meningitis model",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255312,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959514,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,mg/L,UO_0000274,0.06
104653,,3496194,CHEMBL1263991,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus infected in experimental rabbit meningitis model,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255312,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959514,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
104654,,3497173,CHEMBL1264063,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolate COL by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958360,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
104655,,3497174,CHEMBL1264064,Ratio of MIC for methicillin-resistant Staphylococcus aureus COL grown at 37 degC and measured at 37 degC to MIC for methicillin-resistant Staphylococcus aureus COL grown at 37 degC and measured at 15 degC by Etest,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958360,=,1,0,=,Ratio,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4.0
104656,,3497176,CHEMBL1264058,Antimicrobial activity against Staphylococcus aureus BD1 harboring aphA-3 insertion in cspB gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958360,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.064
104657,,3497179,CHEMBL1264057,Antimicrobial activity against Staphylococcus aureus BD2 harboring wild-type cspB gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958360,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104658,,3497182,CHEMBL1264065,Ratio of MIC for methicillin-resistant Staphylococcus aureus COL grown at 15 degC and measured at 37 degC to MIC for methicillin-resistant Staphylococcus aureus COL grown at 15 degC and measured at 15 degC by Etest,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958360,=,1,0,=,Ratio,,2.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,2.4
104659,,3497183,CHEMBL1264059,Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 37 degC and measured at 15 degC by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958360,=,1,1,=,MIC,ug.mL-1,0.46,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.46
104660,,3497185,CHEMBL1264060,Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 37 degC and measured at 37 degC by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958360,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
104661,,3497187,CHEMBL1264061,Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 15 degC and measured at 15 degC by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958360,=,1,1,=,MIC,ug.mL-1,0.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.63
104662,,3497189,CHEMBL1264062,Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL grown at 15 degC and measured at 37 degC by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255491,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958360,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
104663,,3497340,CHEMBL1261266,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates by CLSi method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958367,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104664,,3497349,CHEMBL1261267,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958367,=,1,0,=,Activity,%,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.9
104665,Not Active,3497358,CHEMBL1261268,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958367,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104666,,3497367,CHEMBL1261269,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958367,=,1,0,=,Activity,%,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,99.9
104667,,3497376,CHEMBL1261270,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958367,=,1,0,=,Activity,%,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.1
104668,,3497385,CHEMBL1261266,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates by CLSi method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958367,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104669,,3497396,CHEMBL1261272,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates by CLSi method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958367,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104670,,3497397,CHEMBL1261272,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates by CLSi method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958367,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104671,,3497412,CHEMBL1261273,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958367,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104672,Not Active,3497421,CHEMBL1261274,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,958367,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104673,,3497430,CHEMBL1261275,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958367,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104674,,3497439,CHEMBL1261276,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,958367,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104675,,3536136,CHEMBL1280353,Antibacterial activity against Staphylococcus aureus 42 in absence of 1% bovine pulmonary surfactant by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104676,,3536137,CHEMBL1280354,Antibacterial activity against Staphylococcus aureus 42 in presence of 1% bovine pulmonary surfactant by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
104677,,3536138,CHEMBL1280352,Ratio of MIC for Staphylococcus aureus 42 in presence of 1% bovine pulmonary surfactant to MIC for Staphylococcus aureus 42 in absence of 1% bovine pulmonary surfactant,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968493,=,1,0,=,Ratio,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,128.0
104678,,3536217,CHEMBL1280373,Antibacterial activity against daptomycin sensitive and methicillin susceptible Staphylococcus aureus 42 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104679,,3536218,CHEMBL1280372,Antibacterial activity against daptomycin sensitive and methicillin resistant Staphylococcus aureus 399 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104680,,3536219,CHEMBL1280370,Antibacterial activity against daptomycin sensitive and methicillin resistant Staphylococcus aureus MW2 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104681,,3536220,CHEMBL1280371,Antibacterial activity against daptomycin resistant Staphylococcus aureus 1695 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104682,,3536221,CHEMBL1280368,Antibacterial activity against methicillin resistant Staphylococcus aureus 1616 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
104683,,3536222,CHEMBL1280369,Antibacterial activity against daptomycin sensitive Enterococcus faecium 14 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
104684,,3536223,CHEMBL1280367,Antibacterial activity against daptomycin resistant Enterococcus faecium 384 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
104685,,3536224,CHEMBL1280366,Antibacterial activity against daptomycin sensitive Enterococcus faecalis 201 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
104686,,3536225,CHEMBL1280364,Antibacterial activity against daptomycin resistant Enterococcus faecalis 312 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,128.0
104687,,3536226,CHEMBL1280365,Antibacterial activity against daptomycin sensitive Streptococcus pneumoniae 402 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
104688,,3536227,CHEMBL1280363,Antibacterial activity against imp4213 mutant Escherichia coli BAS849 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275584,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968493,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
104689,,3538706,CHEMBL1282346,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315DeltaIP by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275560,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969473,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104690,,3538713,CHEMBL1282348,Antimicrobial activity against Staphylococcus aureus 10*3d1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275560,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969473,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.0
104691,,3538720,CHEMBL1282350,Antimicrobial activity against Staphylococcus aureus 10*3d1-10 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275560,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969473,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104692,,3538727,CHEMBL1282347,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315DeltaIP by Etest method in presence of 200 uM GdCl3,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275560,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969473,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104693,,3538728,CHEMBL1282349,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 10*3d1 by Etest method in presence of 200 uM GdCl3,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275560,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969473,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.0
104694,Not Determined,3538729,CHEMBL1282351,Antimicrobial activity against Staphylococcus aureus 10*3d1-10 by Etest method in presence of 200 uM GdCl3,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275560,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,969473,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
104695,Active,3538732,CHEMBL1282353,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315DeltaIP assessed as decreased membrane potential,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275560,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,969473,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104696,,3541988,CHEMBL1283216,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104697,,3541990,CHEMBL1283223,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC50,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,0.5
104698,,3541995,CHEMBL1284154,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104699,,3542002,CHEMBL1283216,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
104700,,3542006,CHEMBL1283223,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC90,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,1.0
104701,,3542011,CHEMBL1284154,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
104702,,3542019,CHEMBL1284140,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,2.0
104703,,3542020,CHEMBL1284147,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC50,ug ml-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,2.0
104704,,3542029,CHEMBL1284140,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
104705,,3542032,CHEMBL1284147,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC90,ug ml-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,4.0
104706,,3542033,CHEMBL1284149,Antimicrobial activity against daptomycin-nonsusceptible Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104707,,3542034,CHEMBL1284149,Antimicrobial activity against daptomycin-nonsusceptible Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
104708,,3542035,CHEMBL1284149,Antimicrobial activity against daptomycin-nonsusceptible Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104709,,3542036,CHEMBL1284157,Bactericidal activity against daptomycin-nonsusceptible Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC,ug ml-1,5.94,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,5.94
104710,,3542037,CHEMBL1283221,Bactericidal activity against vancomycin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC90,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,1.0
104711,,3543087,CHEMBL1284157,Bactericidal activity against daptomycin-nonsusceptible Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC50,ug ml-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,8.0
104712,,3543090,CHEMBL1283221,Bactericidal activity against vancomycin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,1.0
104713,,3543120,CHEMBL1283216,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
104714,,3543125,CHEMBL1283223,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.25
104715,,3543126,CHEMBL1284154,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104716,,3543130,CHEMBL1284140,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104717,,3543131,CHEMBL1284147,Bactericidal activity against vancomycin-intermediate Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
104718,,3543144,CHEMBL1284157,Bactericidal activity against daptomycin-nonsusceptible Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,4.0
104719,,3543145,CHEMBL1283221,Bactericidal activity against vancomycin-resistant Staphylococcus aureus assessed as antibiotic concentration that reduced the number of viable cells by =>99.9% by colony count method in presence of 50 mg/L calcium,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
104720,,3543156,CHEMBL1283218,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by microdilution method in presence of 50 mg/L calcium,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968627,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104721,,3543157,CHEMBL1284142,Antimicrobial activity against vancomycin-intermediate Staphylococcus aureus assessed as susceptible isolates by microdilution method in presence of 50 mg/L calcium,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968627,=,1,0,=,Activity,%,35.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,35.0
104722,,3543158,CHEMBL1284144,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus assessed as susceptible isolates by microdilution method in presence of 50 mg/L calcium,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968627,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
104723,,3543159,CHEMBL1284151,Antimicrobial activity against daptomycin-nonsusceptible Staphylococcus aureus assessed as susceptible isolates by microdilution method in presence of 50 mg/L calcium,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968627,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104724,,3543202,CHEMBL1282371,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-2 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104725,,3543203,CHEMBL1282372,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-3 expressing SCCmec type 4 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104726,,3543204,CHEMBL1282373,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-4 expressing SCCmec type 4 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104727,,3543205,CHEMBL1282374,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-5 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104728,,3543206,CHEMBL1282377,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-8 expressing SCCmec element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104729,,3543207,CHEMBL1282378,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-9 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104730,,3543208,CHEMBL1282379,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-10 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104731,,3543215,CHEMBL1284325,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-4 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104732,,3543216,CHEMBL1284327,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-18 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104733,,3543217,CHEMBL1284333,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-27 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104734,,3543218,CHEMBL1284334,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-51 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104735,,3543219,CHEMBL1284335,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-68 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104736,,3543220,CHEMBL1282370,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-1 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104737,,3543221,CHEMBL1282375,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-6 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104738,,3543222,CHEMBL1282376,Antimicrobial activity against vancomycin resistant Staphylococcus aureus VRS-7 expressing SCCmec element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104739,,3543236,CHEMBL1284328,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-19 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104740,,3543237,CHEMBL1284329,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-22 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104741,,3543238,CHEMBL1284330,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-23 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104742,,3543239,CHEMBL1284331,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-24 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104743,,3543240,CHEMBL1284336,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-73 expressing SCCmec type 4d element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104744,,3543241,CHEMBL1284338,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-76 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104745,,3543242,CHEMBL1284340,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-126 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104746,,3543243,CHEMBL1284342,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-403 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104747,,3543244,CHEMBL1285078,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-404 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104748,,3543276,CHEMBL1284324,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-3 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104749,,3543277,CHEMBL1284326,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-17 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104750,,3543278,CHEMBL1284332,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-26 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104751,,3543279,CHEMBL1284337,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-74 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104752,,3543280,CHEMBL1284339,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-118 expressing SCCmec type 1 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104753,,3543287,CHEMBL1284341,Antimicrobial activity against vancomycin intermediate Staphylococcus aureus NRS-402 expressing SCCmec type 2 element by microdilution method in presence of 50 mg/L calcium,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275598,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968627,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
104754,,3544569,CHEMBL1286119,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 375 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968709,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
104755,,3544570,CHEMBL1286119,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 375 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968709,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,1.0
104756,,3544571,CHEMBL1286120,Antimicrobial activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968709,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
104757,,3544572,CHEMBL1286120,Antimicrobial activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968709,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MBC,ug ml-1,UO_0000274,4.0
104758,Active,3544578,CHEMBL1286121,Bactericidal activity against methicillin-resistant Staphylococcus epidermidis 375 at 2 times MIC after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968709,,1,0,,Activity,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,,,
104759,Active,3544579,CHEMBL1286122,Bactericidal activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 at 2 times MIC after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968709,,1,0,,Activity,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,,,
104760,,3544587,CHEMBL1286126,"Cmin in rabbit at 6 mg/kg, iv",A,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968709,=,1,1,=,MIC,ug.mL-1,18.04,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,MIC,ug ml-1,UO_0000274,18.04
104761,,3544588,CHEMBL1286127,"Cmin in rabbit at 10 mg/kg/day, iv",A,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968709,=,1,1,=,MIC,ug.mL-1,18.04,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,MIC,ug ml-1,UO_0000274,18.04
104762,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3544589,CHEMBL1286128,"Cmax in rabbit at 6 mg/kg, iv",A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,968709,=,1,1,=,Cmax,nM,90085.09,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Cmax,ug ml-1,UO_0000065,146.0
104763,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3544590,CHEMBL1286129,"Cmax in rabbit at 10 mg/kg/day, iv",A,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/Nanomolar,968709,=,1,1,=,Cmax,nM,90085.09,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,Cmax,ug ml-1,UO_0000065,146.0
104764,,3544592,CHEMBL1286131,"Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 375 in acute infective endocarditis rabbit model assessed as sterile vegetation level at 6 mg/kg/day, iv after 48 hrs",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968709,=,1,0,=,Activity,%,60.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,60.0
104765,,3544593,CHEMBL1286132,"Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 375 in acute infective endocarditis rabbit model assessed as sterile vegetation level at 10 mg/kg/day, iv after 48 hrs",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968709,=,1,0,=,Activity,%,73.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,73.0
104766,,3544597,CHEMBL1286235,"Antimicrobial activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 in acute infective endocarditis rabbit model assessed as sterile vegetation level at 6 mg/kg/day, iv after 48 hrs",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968709,=,1,0,=,Activity,%,6.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,6.0
104767,,3544598,CHEMBL1286854,"Antimicrobial activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 in acute infective endocarditis rabbit model assessed as sterile vegetation level at 10 mg/kg/day, iv after 48 hrs",F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968709,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104768,,3544599,CHEMBL1286856,"Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 375 in acute infective endocarditis rabbit model assessed as bacterial titer per gram of vegetation at 6 mg/kg/day, iv after 48 hrs",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968709,=,1,0,=,log10cfu,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,0.0
104769,,3544600,CHEMBL1286858,"Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis 375 in acute infective endocarditis rabbit model assessed as bacterial titer per gram of vegetation at 10 mg/kg/day, iv after 48 hrs",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968709,=,1,0,=,log10cfu,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,0.0
104770,,3544603,CHEMBL1286859,"Antimicrobial activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 in acute infective endocarditis rabbit model assessed as bacterial titer per gram of vegetation at 10 mg/kg/day, iv after 48 hrs",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968709,=,1,0,=,log10cfu,,3.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,3.9
104771,,3544604,CHEMBL1286857,"Antimicrobial activity against glycopeptide-intermediate Staphylococcus epidermidis NRS6 in acute infective endocarditis rabbit model assessed as bacterial titer per gram of vegetation at 6 mg/kg/day, iv after 48 hrs",F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968709,=,1,0,=,log10cfu,,3.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,3.7
104772,,3544608,CHEMBL1286863,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolates,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275602,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968709,>=,1,1,>=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
104773,,3566955,CHEMBL1278288,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104774,,3566956,CHEMBL1278287,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104775,,3566957,CHEMBL1278286,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104776,,3566958,CHEMBL1278285,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104777,,3566959,CHEMBL1278284,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104778,,3566960,CHEMBL1278283,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104779,,3566961,CHEMBL1278282,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104780,,3566962,CHEMBL1278281,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104781,,3566963,CHEMBL1278280,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104782,,3566964,CHEMBL1278279,Antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
104783,,3566965,CHEMBL1279494,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104784,,3566966,CHEMBL1279493,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104785,,3566967,CHEMBL1279492,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104786,,3566968,CHEMBL1279256,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104787,,3566969,CHEMBL1279254,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104788,,3566970,CHEMBL1279253,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104789,,3566971,CHEMBL1279252,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104790,,3566972,CHEMBL1279251,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
104791,,3566973,CHEMBL1279244,Antimicrobial activity against vancomycin-resistant Enterococcus sp. assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,0.0
104792,,3566974,CHEMBL1279245,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,0.0
104793,,3566975,CHEMBL1279243,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient urine assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,0.0
104794,,3566976,CHEMBL1279242,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,0.0
104795,,3566977,CHEMBL1279241,Antimicrobial activity against vancomycin-resistant Enterococcus sp. isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968390,=,1,0,=,Activity,%,0.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,Activity,%,UO_0000187,0.0
104796,Not Determined,3567225,CHEMBL1279250,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968390,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104797,Not Determined,3567226,CHEMBL1279248,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient blood assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968390,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104798,Not Determined,3567227,CHEMBL1279247,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient wound assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968390,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104799,Not Determined,3567228,CHEMBL1279246,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968390,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
104800,Not Determined,3567233,CHEMBL1279255,Antimicrobial activity against methicillin-susceptible Staphylococcus epidermidis isolated from ICU patient respiratory tract assessed as resistant isolates by broth microdilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275409,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968390,,1,0,,Activity,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,,,
104801,,3569999,CHEMBL1281802,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 277 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968333,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
104802,,3570000,CHEMBL1281803,Antimicrobial activity against glycopeptide-intermediate Staphylococcus aureus ATCC 700788 by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968333,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104803,,3570002,CHEMBL1281803,Antimicrobial activity against glycopeptide-intermediate Staphylococcus aureus ATCC 700788 by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968333,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.0
104804,Active,3570004,CHEMBL1281659,Bactericidal activity against methicillin-resistant Staphylococcus aureus 277 at 0.5 to 4 times MIC by time-kill experiment,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968333,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104805,Active,3570005,CHEMBL1281660,Bactericidal activity against glycopeptide-intermediate Staphylococcus aureus ATCC 700788 at 0.5 to 4 times MIC by time-kill experiment,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968333,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104806,,3570025,CHEMBL1281799,"Terminal half-life in New Zealand White rabbit at 6 mg/kg, iv administered every 24 hrs",A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,968333,=,1,1,=,T1/2,hr,0.19,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,t1/2,hr,UO_0000032,0.19
104807,,3570026,CHEMBL1281800,"AUC in New Zealand White rabbit at 6 mg/kg, iv administered every 24 hrs",A,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968333,=,1,1,=,AUC,ng.hr.mL-1,3570.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,AUC,ug.hr/ml,,3.57
104808,,3570028,CHEMBL1281804,Ratio of AUC to MIC for methicillin-resistant Staphylococcus aureus 277 in PK/PD model,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968333,=,1,0,=,Ratio,,7047.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,7047.5
104809,,3570029,CHEMBL1280243,Ratio of AUC to MIC for glycopeptide-intermediate Staphylococcus aureus ATCC 700788 in PK/PD model,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968333,=,1,0,=,Ratio,,1691.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,1691.4
104810,,3570034,CHEMBL1280237,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968333,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
104811,,3570035,CHEMBL1280238,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 72 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275432,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968333,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104812,,3570390,CHEMBL1280330,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,1.0
104813,,3570391,CHEMBL1280330,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC90,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,1.0
104814,,3570392,CHEMBL1280330,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
104815,,3570393,CHEMBL1280331,Bactericidal activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC50,ug ml-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,0.25
104816,,3570394,CHEMBL1280331,Bactericidal activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
104817,,3570396,CHEMBL1280331,Bactericidal activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC90,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,1.0
104818,,3570405,CHEMBL1280332,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.125
104819,,3570406,CHEMBL1280332,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC50,ug ml-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,0.25
104820,,3570407,CHEMBL1280332,Bactericidal activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC90,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,0.5
104821,,3570780,CHEMBL1278403,Antimicrobial activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104822,,3570781,CHEMBL1278403,Antimicrobial activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
104823,,3570782,CHEMBL1278402,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
104824,,3570783,CHEMBL1278402,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,1.0
104825,,3570784,CHEMBL1278401,Antimicrobial activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104826,,3570785,CHEMBL1278401,Antimicrobial activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104827,,3570792,CHEMBL1278400,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104828,,3570793,CHEMBL1278400,Antimicrobial activity against community-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104829,,3570800,CHEMBL1280329,Bactericidal activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC90,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,1.0
104830,,3570801,CHEMBL1280329,Bactericidal activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC50,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,1.0
104831,,3570802,CHEMBL1280329,Bactericidal activity against hospital-acquired methicillin-resistant Staphylococcus aureus by broth microdilution method in presence of 50% human serum,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275473,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969340,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.5
104832,,3571956,CHEMBL1278974,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanA clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
104833,,3571967,CHEMBL1278975,Antibacterial activity against Streptococcus viridans clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,Activity,%,UO_0000187,100.0
104834,,3571976,CHEMBL1278976,Antibacterial activity against Streptococcus constellatus clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,Activity,%,UO_0000187,100.0
104835,,3571984,CHEMBL1278977,Antibacterial activity against Streptococcus oralis clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,Activity,%,UO_0000187,100.0
104836,,3571993,CHEMBL1278978,Antibacterial activity against Streptococcus intermedius clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,Activity,%,UO_0000187,100.0
104837,,3572003,CHEMBL1278979,Antibacterial activity against Streptococcus mitis clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,Activity,%,UO_0000187,100.0
104838,,3572012,CHEMBL1278980,Antibacterial activity against Streptococcus agalactiae group B clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,%,UO_0000187,100.0
104839,,3572022,CHEMBL1278981,Antibacterial activity against Streptococcus pyogenes group A clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,100.0
104840,,3572057,CHEMBL1278985,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,Activity,%,UO_0000187,100.0
104841,,3572065,CHEMBL1278986,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
104842,,3572073,CHEMBL1278987,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,100.0
104843,,3572082,CHEMBL1278988,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,Activity,%,UO_0000187,100.0
104844,,3572090,CHEMBL1278989,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,100.0
104845,,3572097,CHEMBL1278990,Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
104846,,3572105,CHEMBL1278991,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,98.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,98.0
104847,,3572114,CHEMBL1278992,Antibacterial activity against vancomycin resistant Enterococcus faecium VanB clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
104848,,3572117,CHEMBL1278992,Antibacterial activity against vancomycin resistant Enterococcus faecium VanB clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,2.0
104849,,3572118,CHEMBL1278992,Antibacterial activity against vancomycin resistant Enterococcus faecium VanB clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.25
104850,,3572137,CHEMBL1278993,Antibacterial activity against vancomycin resistant Enterococcus faecium VanA clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,4.0
104851,,3572138,CHEMBL1278993,Antibacterial activity against vancomycin resistant Enterococcus faecium VanA clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
104852,,3572139,CHEMBL1278993,Antibacterial activity against vancomycin resistant Enterococcus faecium VanA clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,2.0
104853,Not Active,3572512,CHEMBL1278994,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanB clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC90,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,,,
104854,Not Active,3572513,CHEMBL1278994,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanB clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC50,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,,,
104855,,3572514,CHEMBL1278994,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanB clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
104856,,3572529,CHEMBL1278995,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanA clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
104857,,3572531,CHEMBL1278995,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanA clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,2.0
104858,,3572532,CHEMBL1278995,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanA clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
104859,Not Active,3572572,CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC90,,,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC90,,,
104860,Not Active,3572573,CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC50,,,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC50,,,
104861,,3572574,CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,MIC,ug ml-1,UO_0000274,0.25
104862,Not Active,3572608,CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC90,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC90,,,
104863,Not Active,3572609,CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC50,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC50,,,
104864,,3572610,CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC,ug ml-1,UO_0000274,0.25
104865,,3572644,CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,0.25
104866,Not Active,3572645,CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC50,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC50,,,
104867,Not Active,3572646,CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC90,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC90,,,
104868,Not Active,3572680,CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC90,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC90,,,
104869,,3572682,CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC,ug ml-1,UO_0000274,0.25
104870,Not Active,3572683,CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC50,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC50,,,
104871,Not Active,3572716,CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC90,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC90,,,
104872,Not Active,3572717,CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,968406,,1,0,,MIC50,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC50,,,
104873,,3572718,CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.25
104874,,3572752,CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,0.25
104875,,3572753,CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.25
104876,,3572754,CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.06
104877,,3572788,CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.25
104878,,3572789,CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,<=,1,1,<=,MIC50,ug.mL-1,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.03
104879,,3572790,CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.03
104880,,3572824,CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
104881,,3572825,CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
104882,,3572826,CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.12
104883,,3573210,CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
104884,,3573211,CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
104885,,3573212,CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.12
104886,,3573246,CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
104887,,3573247,CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.12
104888,,3573248,CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
104889,,3573267,CHEMBL1279006,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.12
104890,,3573268,CHEMBL1279006,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,0.25
104891,,3573269,CHEMBL1279006,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,1.0
104892,,3573294,CHEMBL1279007,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
104893,,3573295,CHEMBL1279007,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.25
104894,,3573296,CHEMBL1279007,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1.0
104895,,3573321,CHEMBL1279008,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.12
104896,,3573322,CHEMBL1279008,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,0.25
104897,,3573323,CHEMBL1279008,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,1.0
104898,,3573348,CHEMBL1279009,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC,ug ml-1,UO_0000274,0.12
104899,,3573349,CHEMBL1279009,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC50,ug ml-1,UO_0000274,0.25
104900,,3573350,CHEMBL1279009,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,MIC90,ug ml-1,UO_0000274,1.0
104901,,3573375,CHEMBL1279010,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
104902,,3573376,CHEMBL1279010,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.25
104903,,3573377,CHEMBL1279010,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,1.0
104904,,3573402,CHEMBL1279011,Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
104905,,3573403,CHEMBL1279011,Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.5
104906,,3573404,CHEMBL1279011,Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,1.0
104907,,3573433,CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
104908,,3573434,CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
104909,,3573435,CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968406,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104910,,3573436,CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,98.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,98.0
104911,,3573453,CHEMBL1278973,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanB clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
104912,,3573459,CHEMBL1278926,Antibacterial activity against vancomycin resistant Enterococcus faecium VanA clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,98.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,98.0
104913,,3573465,CHEMBL1278925,Antibacterial activity against vancomycin resistant Enterococcus faecium VanB clinical isolate assessed as susceptibility level by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Percent,968406,=,1,0,=,Activity,%,93.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,93.0
104914,,5079717,CHEMBL1614671,Clearance in human after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1310724,=,1,1,=,CL,mL.min-1.kg-1,0.16,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,0.16
104915,,5080030,CHEMBL1614672,Fraction unbound in human after iv administration,A,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1310724,=,1,1,=,Fu,,0.083,CHEMBL3879801,,NON-PROTEIN TARGET,,,fu,,,0.083
104916,,5080039,CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1310724,=,1,1,=,Vdss,L.kg-1,0.088,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,0.088
104917,,5082725,CHEMBL1614674,Half life in human after iv administration,A,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://qudt.org/vocab/unit#Hour,1310724,=,1,1,=,T1/2,hr,8.1,CHEMBL612558,,ADMET,,,t1/2,h,UO_0000032,8.1
104918,Active,5086579,CHEMBL1636954,Bactericidal activity against exponential-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 grown on nutrient-depleted CAMHB medium at 0.5 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104919,Active,5086580,CHEMBL1636956,Bactericidal activity against exponential-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 grown on nutrient-depleted CAMHB medium at 4 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104920,Active,5086581,CHEMBL1636955,Bactericidal activity against exponential-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 grown on nutrient-depleted CAMHB medium at 16 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104921,Not Active,5086590,CHEMBL1636952,Bactericidal activity against stationary-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 grown on nutrient-depleted CAMHB medium at 16 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104922,Not Active,5086592,CHEMBL1636953,Bactericidal activity against stationary-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 grown on nutrient-depleted CAMHB medium at 4 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104923,Active,5086598,CHEMBL1636961,Bactericidal activity against stationary-phase methicillin-resistant Staphylococcus aureus ATCC 33591 grown on nutrient-depleted CAMHB medium at 4 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104924,Active,5086600,CHEMBL1636962,Bactericidal activity against stationary-phase methicillin-resistant Staphylococcus aureus ATCC 33591 grown on nutrient-depleted CAMHB medium at 2 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104925,Not Active,5086602,CHEMBL1636963,Bactericidal activity against stationary-phase vancomycin-resistant Staphylococcus aureus isolate VRS5 grown on nutrient-depleted CAMHB medium at 4 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104926,Not Active,5086604,CHEMBL1636964,Bactericidal activity against stationary-phase vancomycin-resistant Staphylococcus aureus ATCC 33591 grown on nutrient-depleted CAMHB medium at 2 ug/ml after 24 hrs by time kill analysis,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104927,Not Active,5086612,CHEMBL1637815,Antimicrobial activity against stationary-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 assessed as membrane permeability at 4 ug/ml after 30 mins by propidium iodide staining-based fluorescence spectrophotometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104928,Active,5086613,CHEMBL1637816,Antimicrobial activity against exponential-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 assessed as membrane permeability at 4 ug/ml after 30 mins by propidium iodide staining-based fluorescence spectrophotometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104929,,5086617,CHEMBL1637818,Bactericidal activity against exponential-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 assessed as log reduction in bacterial count at 4 ug/ml within 2 hrs by time kill analysis,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,=,1,0,=,FC,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,3.4
104930,,5086619,CHEMBL1637819,Bactericidal activity against stationary-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 assessed as log reduction in bacterial count at 4 ug/ml within 2 hrs by time kill analysis,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,=,1,0,=,FC,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,0.7
104931,,5096774,CHEMBL1636732,Antimicrobial activity against Staphylococcus epidermidis Xen 43 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1312942,=,1,0,=,log10cfu,,-0.38,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,-0.38
104932,,5096782,CHEMBL1636728,Antimicrobial activity against Staphylococcus aureus Xen 30 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1312942,=,1,0,=,log10cfu,,1.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,1.63
104933,,5096789,CHEMBL1636733,Antimicrobial activity against Staphylococcus epidermidis Xen 43 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 2000 microamperes of electric current by bioelectric effect assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1312942,=,1,0,=,log10cfu,,1.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,1.2
104934,,5096798,CHEMBL1636730,Antimicrobial activity against Staphylococcus aureus Xen 30 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 200 microamperes of electric current by bioelectric effect assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1312942,=,1,0,=,log10cfu,,1.94,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,1.94
104935,,5096812,CHEMBL1636724,Antimicrobial activity against Staphylococcus epidermidis Xen 43 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312942,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
104936,,5096820,CHEMBL1635872,Antimicrobial activity against Staphylococcus aureus Xen 30 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312942,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
104937,Not Active,5097328,CHEMBL1636947,Antimicrobial activity against stationary-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 membrane depolarization at 4 ug/ml after 30 mins using DiSC3(5) dye based fluorescence spectrophotometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104938,Active,5097329,CHEMBL1636946,Antimicrobial activity against exponential-phase methicillin-sensitive Staphylococcus aureus ATCC 29213 assessed as membrane depolarization at 4 ug/ml after 30 mins using DiSC3(5) dye based fluorescence spectrophotometry,F,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629656,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1315576,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
104939,,5105315,CHEMBL1638992,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,2.0
104940,,5105316,CHEMBL1638993,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,1.0
104941,,5105317,CHEMBL1638994,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.0015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,1.5
104942,,5105318,CHEMBL1638995,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 24 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.0015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,1.5
104943,,5105319,CHEMBL1638996,"Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 24 hrs by Etest",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,2.0
104944,,5105320,CHEMBL1639733,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,2.0
104945,,5105321,CHEMBL1639734,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.001,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,1.0
104946,,5105322,CHEMBL1639735,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.0015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,1.5
104947,,5105323,CHEMBL1639736,Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 48 hrs by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.0015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,1.5
104948,,5105324,CHEMBL1639737,"Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 48 hrs by Etest",F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629665,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313927,=,1,1,=,MIC,ug.mL-1,0.002,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug/L,UO_0000274,2.0
104949,,5109665,CHEMBL1638307,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as >=3log10 CFU/ml reduction in bacterial growth after 24 to 48 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629676,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314769,=,1,0,=,MBC90,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC90,ug ml-1,UO_0000274,1.0
104950,,5109666,CHEMBL1638307,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as >=3log10 CFU/ml reduction in bacterial growth after 24 to 48 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629676,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314769,=,1,0,=,MBC50,ug ml-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC50,ug ml-1,UO_0000274,0.5
104951,,5109667,CHEMBL1638306,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth dilution assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629676,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314769,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.5
104952,,5109668,CHEMBL1638306,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by broth dilution assay,F,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629676,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314769,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.5
104953,,5119413,CHEMBL1639463,Antimicrobial activity against Staphylococcus aureus CB1482 after 24 hrs by plate reader analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104954,,5119414,CHEMBL1639464,Antimicrobial activity against Staphylococcus aureus CB184 after 24 hrs by plate reader analysis,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
104955,,5119415,CHEMBL1639465,Antimicrobial activity against Staphylococcus aureus CB5053 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104956,,5119416,CHEMBL1639466,Antimicrobial activity against Staphylococcus aureus CB5054 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104957,,5119417,CHEMBL1639467,Antimicrobial activity against Staphylococcus aureus CB5035 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.38
104958,,5119418,CHEMBL1639468,Antimicrobial activity against Staphylococcus aureus CB5036 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104959,,5119419,CHEMBL1639469,Antimicrobial activity against Staphylococcus aureus BMC1001 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
104960,,5119420,CHEMBL1639470,Antimicrobial activity against Staphylococcus aureus BMC1002 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
104961,,5119429,CHEMBL1639473,Binding affinity to methicillin-susceptible Staphylococcus aureus 11/11 cell membrane assessed as amount of compound bound at 6 ug after 10 mins,B,BAO_0000181,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,0,=,Activity,ug ml-1,2.03,CHEMBL2364031,Bacteria,Cell membrane,2.0,,Activity,ug ml-1,UO_0000274,2.03
104962,,5119430,CHEMBL1639474,Binding affinity to daptomycin-resistant Staphylococcus aureus REF2145 cell membrane assessed as amount of compound bound at 6 ug after 10 mins,B,BAO_0000181,BAO_0000019,assay format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,0,=,Activity,ug ml-1,0.79,CHEMBL2364031,Bacteria,Cell membrane,2.0,,Activity,ug ml-1,UO_0000274,0.79
104963,,5119433,CHEMBL1639471,AUC in methicillin-susceptible sStaphylococcus aureus 11/11,A,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,0,=,AUC,ug ml-1,8.41,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,AUC,ug ml-1,UO_0000274,8.41
104964,,5119434,CHEMBL1639472,AUC in daptomycin-resistant sStaphylococcus aureus REF2145,A,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629699,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313074,=,1,0,=,AUC,ug ml-1,30.64,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,AUC,ug ml-1,UO_0000274,30.64
104965,,5119454,CHEMBL1640495,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,0.975,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.975
104966,,5119455,CHEMBL1640496,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% human serum ultrafiltrate,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,0.513,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.513
104967,,5119456,CHEMBL1639478,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% human serum,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.0
104968,,5119457,CHEMBL1640484,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% mouse serum ultrafiltrate,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,3.0
104969,,5119458,CHEMBL1640485,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% mouse serum,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.5
104970,,5119459,CHEMBL1639600,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% rat serum ultrafiltrate,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,0.538,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.538
104971,,5119460,CHEMBL1639601,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% rat serum,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.56
104972,,5119461,CHEMBL1639606,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% dog serum ultrafiltrate,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,0.638,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.638
104973,,5119462,CHEMBL1639607,Antibacterial activity against Staphylococcus aureus ATCC 29213 grown in CAMHB medium by broth microdilution method in presence of 50 ug/ml CaCl2 and 95% dog serum,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313077,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.5
104974,,5119463,CHEMBL1639608,Ratio of MIC for Staphylococcus aureus ATCC 29213 grown in CAMHB medium in presence of 95% human serum to MIC for Staphylococcus aureus ATCC 29213 in presence of 95% human serum ultrafiltrate,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1313077,=,1,0,=,Ratio,,5.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,5.8
104975,,5119464,CHEMBL1639479,Ratio of MIC for Staphylococcus aureus ATCC 29213 grown in CAMHB medium in presence of 95% mouse serum to MIC for Staphylococcus aureus ATCC 29213 in presence of 95% mouse serum ultrafiltrate,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1313077,=,1,0,=,Ratio,,4.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,4.2
104976,,5119465,CHEMBL1639480,Ratio of MIC for Staphylococcus aureus ATCC 29213 grown in CAMHB medium in presence of 95% rat serum to MIC for Staphylococcus aureus ATCC 29213 in presence of 95% rat serum ultrafiltrate,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1313077,=,1,0,=,Ratio,,2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,2.9
104977,,5119466,CHEMBL1639481,Ratio of MIC for Staphylococcus aureus ATCC 29213 grown in CAMHB medium in presence of 95% dog serum to MIC for Staphylococcus aureus ATCC 29213 in presence of 95% dog serum ultrafiltrate,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1629700,Antimicrob Agents Chemother,2010.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1313077,=,1,0,=,Ratio,,3.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Ratio,,,3.9
104978,,5146359,CHEMBL1664959,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
104979,,5146360,CHEMBL1664960,Antimicrobial activity against vancomycin-resistant Enterococcus faecium ATCC 51559 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
104980,,5146361,CHEMBL1664961,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
104981,,5146362,CHEMBL1664962,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis 1058946 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
104982,,5146363,CHEMBL1664963,Antimicrobial activity against vancomycin-resistant Enterococcus faecium 1119175 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,4.0
104983,,5146364,CHEMBL1664964,Antimicrobial activity against vancomycin-resistant Enterococcus faecium 1059060 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,1.0
104984,,5146365,CHEMBL1664965,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212 by broth dilution method in presence of 4% HSA,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
104985,,5146366,CHEMBL1664966,Antimicrobial activity against vancomycin-resistant Enterococcus faecium ATCC 51559 by broth dilution method in presence of 4% HAS,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
104986,,5146367,CHEMBL1664967,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 by broth dilution method in presence of 4% HSA,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
104987,,5146368,CHEMBL1664968,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis 1058946 by broth dilution method in presence of 4% HSA,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
104988,,5146369,CHEMBL1664969,Antimicrobial activity against vancomycin-resistant Enterococcus faecium 1119175 by broth dilution method in presence of 4% HSA,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,64.0
104989,,5146370,CHEMBL1664970,Antimicrobial activity against vancomycin-resistant Enterococcus faecium 1059060 by broth dilution method in presence of 4% HSA,F,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326486,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
104990,,5146371,CHEMBL1664971,Selectivity ratio of MIC for Enterococcus faecalis ATCC 29212 in presence of 4% HSA to MIC for Enterococcus faecalis ATCC 29212,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,Ratio,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Ratio,,,16.0
104991,,5146372,CHEMBL1664972,Selectivity ratio of MIC for Enterococcus faecium ATCC 51559 in presence of 4% HSA to MIC for Enterococcus faecium ATCC 51559,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,Ratio,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Ratio,,,16.0
104992,,5146373,CHEMBL1664973,Selectivity ratio of MIC for Enterococcus faecalis ATCC 51299 in presence of 4% HSA to MIC for Enterococcus faecalis 51299,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,Ratio,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Ratio,,,16.0
104993,,5146374,CHEMBL1664974,Selectivity ratio of MIC for Enterococcus faecalis 1058946 in presence of 4% HSA to MIC for Enterococcus faecalis 1058946,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,Ratio,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Ratio,,,8.0
104994,,5146375,CHEMBL1664975,Selectivity ratio of MIC for Enterococcus faecium 1119175 in presence of 4% HSA to MIC for Enterococcus faecium 1119175,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,Ratio,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Ratio,,,16.0
104995,,5146376,CHEMBL1664976,Selectivity ratio of MIC for Enterococcus faecium 1059060 in presence of 4% HSA to MIC for Enterococcus faecium 1059060,F,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,Ratio,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Ratio,,,8.0
104996,,5146377,CHEMBL1667443,Bactericidal activity against vancomycin-susceptible Enterococcus faecalis ATCC 29212 assessed as change in bacterial count at 64 ug/ml by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,log10CFU/ml,,0.26,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,log10CFU/ml,,,0.26
104997,,5146378,CHEMBL1667444,Bactericidal activity against vancomycin-resistant Enterococcus faecium ATCC 51559 expressing vanA gene assessed as change in bacterial count at 64 ug/ml by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,log10CFU/ml,,1.4,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,log10CFU/ml,,,1.4
104998,,5146379,CHEMBL1667445,Bactericidal activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 expressing vanB gene assessed as change in bacterial count at 64 ug/ml by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,log10CFU/ml,,1.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,log10CFU/ml,,,1.4
104999,,5146380,CHEMBL1667446,Bactericidal activity against vancomycin-resistant Enterococcus faecalis 1058946 expressing vanA gene assessed as change in bacterial count at 64 ug/ml by time-kill assay,F,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]1C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@@H]([C@H](C)CC(=O)O)C(=O)N[C@@H](CC(=O)c2ccccc2N)C(=O)O[C@@H]1C,CHEMBL1649467,Antimicrob Agents Chemother,2009.0,CHEMBL387675,DAPTOMYCIN,CHEMBL387675,0,,1326486,=,1,0,=,log10CFU/ml,,-0.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,log10CFU/ml,,,-0.4
